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Metabolic flexibility is commonly measured as the change in respiratory quotient 
(RQ) from the fasted state to the insulin-stimulated state.  This measurement is 
performed using a hyperinsulinemic-euglycemic clamp and hood calorimetry. A 
study was performed to evaluate if room calorimetry alone could provide the same 
results and to examine how diet composition and exercise affect metabolic flexibility.  
Sixteen healthy males and females stayed overnight in a room calorimeter on four 
separate occasions.  While in the calorimeter, they participated in meal and exercise 
challenges.  The subjects took part in one of two exercise sessions on the treadmill 
(high intensity – short duration or low intensity – long duration).  They were also 
provided one of two treatment beverages for lunch (high carbohydrate or high fat 
shake).  Blood samples were collected before and 30, 60, 90, and 120 minutes after 
breakfast and lunch to measure glucose, insulin, and non-esterified fatty acids 
(NEFAs).  Metabolic flexibility was calculated in a manner similar to the literature, 
and new metabolic flexibility variables were also considered including the rate of 
  
change of RQ (slope) following exercise or a meal and the lag in RQ following 
exercise.  Delta RQ - calculated as the difference between a two hour average night 
RQ and a two hour average morning RQ - was negatively correlated to % body fat, 
positively correlated to VO2peak, and trending negatively with age.  The post-lunch 
slope of RQ was significantly larger following the high carbohydrate shake compared 
to the high fat shake.  The slope of the increase in RQ following the start of exercise 
was negatively correlated with age and % body fat and positively correlated with 
VO2peak.  This study shows that the non-invasive room calorimetry method can be 
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AC  Acylcarnitines 
AMPK  Adenosine monophosphate-activated protein kinase 
AUC  Area under the curve 
BG  Blood glucose 
BHNRC Beltsville Human Nutrition Research Center 
BMI  Body mass index 
CBC  Complete blood count 
CDC  Centers for Disease Control and Prevention 
CGMS  Continuous glucose monitoring system 
CK  Creatine kinase 
CPT 1b Carnitine palmitoyltransferase 1b 
CS  Citrate synthase 
CT  Computed tomography 
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FQ  Food quotient 
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GDR  Glucose disposal rate 
1H NMR Proton nuclear magnetic resonance 
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HF  High fat 
HI  High intensity – short duration 
HOMA-IR Homeostatic model assessment – insulin resistance 
HR  Heart rate 
HSF  Human Studies Facility 
HU  Hounsfield units   
IFG  Impaired fasting glycemia 
IGT  Impaired glucose tolerance 
IHL  Intrahepatic lipid 
IMCL  Intramyocellular lipid 
IR  Insulin resistance 
IRβ  Insulin receptor β 
IRB  Institutional Review Board 
IS  Insulin sensitivity 
LA  Linoleic acid 
LI  Low intensity – long duration 
LXR  Liver X receptor 
MCD1  Malonyl-coenzyme A decarboxylase 1 




MS  Multiple sclerosis 
mtDNA Mitochondrial deoxyribonucleic acid 
NAFLD Non-alcoholic fatty liver disease 
NEFA  Non-esterified fatty acid 
NGT  Normal glucose tolerance 
NHANES National Health and Nutrition Examination Survey 
OGTT  Oral glucose tolerance test 
PA  Palmitic acid 
PAL  Physical activity level 
PCK1  Phosphoenolpyruvate carboxykinase 1 
PDK2 (or 4) Pyruvate dehydrogenase kinase isozyme 2 (or 4) 
PCOS  Polycystic ovary syndrome 
PFK  Phosphofructokinase 
PGC1α Peroxisome proliferator-activated receptor gamma coactivator-1α 
PPARα Peroxisome proliferator-activated receptor-α 
PPARγ2 Peroxisome proliferator-activated receptor-γ2 
RER  Respiratory exchange ratio 
RPE  Rate of perceived exertion 
RQ  Respiratory quotient 
SCD1  Stearoyl-Coenzyme A desaturase 1 
SEM  Sensor electronic module 
sTNFR1(or 2) Soluble tumor necrosis factor-α receptors 
T1D  Type 1 Diabetes 
T2D  Type 2 Diabetes 
TSH  Thyroid-stimulating hormone 
VCO2  Volume of carbon dioxide 
VO2  Volume of oxygen 
UN  Urinary nitrogen 





Table of Contents 
 
 
Dedication ..................................................................................................................... ii 
Acknowledgements ...................................................................................................... iii 
Abbreviations ............................................................................................................... iv 
Table of Contents ......................................................................................................... vi 
List of Tables ............................................................................................................. viii 
List of Figures .............................................................................................................. ix 
Introduction ................................................................................................................... 1 
Chapter 1: Literature Review ........................................................................................ 3 
1.1.1 Introduction .................................................................................................. 3 
1.1.2 Overview ...................................................................................................... 5 
1.2 Metabolic Factors................................................................................................ 6 
1.2.1 Substrate Utilization..................................................................................... 6 
1.2.2 Insulin .......................................................................................................... 7 
1.2.3 Calorimetry .................................................................................................. 8 
1.3 Tissue Factors ................................................................................................... 13 
1.3.1   Skeletal Muscle Mitochondria ................................................................. 13 
1.3.2 Skeletal Muscle IMCL ............................................................................... 14 
1.3.3 Skeletal Muscle Cells ................................................................................. 16 
1.3.4 MF Correlations ......................................................................................... 19 
1.4 Genetic, Gender, and Racial Factors................................................................. 21 
1.4.1 Family History ........................................................................................... 21 
1.4.2 Gender ........................................................................................................ 23 
1.4.3 Race............................................................................................................ 24 
1.4.4 Medical Conditions .................................................................................... 25 
1.5 Environmental Factors ...................................................................................... 27 
1.5.1 Diet ............................................................................................................. 27 
1.5.2 Caloric restriction....................................................................................... 30 
1.5.3 Exercise ...................................................................................................... 31 
Chapter 2: Metabolic Flexibility: Adaptation to Diet and Exercise Challenges ......... 35 
2.1. Abstract ............................................................................................................ 35 
2.2 Introduction ....................................................................................................... 36 
2.3 Methods............................................................................................................. 38 
2.3.1 Subjects ...................................................................................................... 38 
2.3.2 Design ........................................................................................................ 41 
2.3.3 Diet ............................................................................................................. 41 
2.3.4 Exercise ...................................................................................................... 43 
2.3.5 Calorimeter ................................................................................................ 45 
2.3.6 Blood Draws .............................................................................................. 46 
2.3.7 Urine Collection ......................................................................................... 47 
2.3.8 Body Fat Composition ............................................................................... 48 
2.3.9 Schedule ..................................................................................................... 49 




2.4 Results ............................................................................................................... 52 
2.4.1 Energy Expenditure and Substrate Oxidation ............................................ 52 
2.4.2 Metabolic Flexibility in Response to Meals .............................................. 54 
2.4.3 Metabolic Flexibility during Exercise ....................................................... 58 
2.4.4 Glucose, Insulin, and NEFAs..................................................................... 61 
2.5 Discussion ......................................................................................................... 63 
Chapter 3: Conclusions and Future Work ................................................................... 69 
Appendix A: Summary of Select Metabolic Flexibility Articles................................ 71 
Appendix B: Curriculum vitae .................................................................................... 77 















List of Tables 
 
Table 2.1: Ineligibility Criteria………………………………………………………39 
Table 2.2: Day 2 Standardized Menu………………………………………………..42 
Table 2.3: Bruce Protocol……………………………………………………………44 
Table 2.4: Physical characteristics of the subjects…………………………………...52 
Table 2.5: RQ and insulin variances………………………………………………....58 




List of Figures 
Figure 1.1: Room calorimeter…………………………………………………………9 
Figure 1.2: Study participant………………………………………………………….9  
Figure 1.3: Subject lag following exercise……………………….……………….....12 
Figure 1.4: Average lag time vs. age………………………………………………...12 
 
Figure 2.1: Subject selection flowchart……………………………………………..40 
Figure 2.2: Schedule for Day 1 and Day 2 of the calorimeter session……………...51 
Figure 2.3: Macronutrient oxidation………………………………………………..53 
Figure 2.4: Lunch slope……………………………………………………………..54 
Figure 2.5: ∆RQ correlations………………………………………………………..56 
Figure 2.6: Pre-meal RQ…………………………………………………………………....57 
Figure 2.7: Exercise RQ slopes……...……………………………………………...59 
Figure 2.8: Post exercise lag time…………………………………………………..60 







 Metabolic flexibility is the ability to switch substrate use based on substrate availability.  
For example, while sleeping at night, a person is in a fasted state and therefore is using more fat.  
When they wake up and eat breakfast, they are now in an insulin-stimulated state and will switch 
to using glucose as their fuel source.  Much of the literature measures metabolic flexibility as the 
change in respiratory quotient (RQ) between an insulin-stimulated state and a fasting state.  This 
measurement is done using a hyperinsulinemic-euglycemic clamp and a hood calorimeter.  By 
utilizing a smoothing method that reduces equipment noise, it is possible to use a room 
calorimeter to study metabolic flexibility.  Using a room calorimeter is beneficial for several 
reasons.  First, it is less invasive that the clamp method, which involves infusion of insulin and 
glucose.  Second, the room calorimeter allows the body to have a more physiological response to 
diet or exercise challenges than the clamp which involves controlling glucose levels.  Finally, the 
clamp would not allow for eating meals or exercising during the procedure; therefore using the  
room calorimeter and smoothing the data allows the subjects to consume actual meals and be 
ambulatory to exercise so that RQ response can be monitored continuously.   
The first chapter will provide background on metabolic flexibility and the second chapter 
will focus on using room calorimeter to measure metabolic flexibility and evaluating how 
subjects adapt their RQ to diet and exercise challenges.  The primary objectives were (1) to 
verify that measuring metabolic flexibility using a room calorimeter would provide similar 
results to other methodologies; (2) to examine the effects of diet composition and exercise 




of RQ); and (3) to see if there are any correlations that can be established between the metabolic 
flexibility variables and the physical characteristics of the subjects (age, BMI, % body fat, 























Chapter 1: Literature Review 
1.1.1 Introduction 
 
Obesity is a major health concern that has reached epidemic proportions in the United 
States.  According to the National Health and Nutrition Examination Survey (NHANES) from 
2009 – 2010, 35.7% of adults (35.8% women; 35.5% men) in the U.S. were obese [1, 2] and 
16.9% of children and adolescents in the U.S. were obese [2, 3].  Healthy People 2010 set a goal 
to reduce the incidence of obesity to 15%, and in 2009, using self-reported heights and weights, 
all states’ obesity rates exceeded this percentage [4].  The Healthy People 2020 objective is to 
reduce the incidence of obesity to 30.6% [5], and nine states from the previous study had an 
obesity prevalence of  ≥ 30% [4].  In 2010, 36 states had an obesity prevalence of 25% or more 
with 12 states ≥ 30%.  Much of this has to do with energy balance: we are taking in more 
calories than we are using.  With the increased incidence of obesity comes the higher risk of 
developing other health problems including Type 2 diabetes (T2D).  According to the CDC 
National Diabetes Fact Sheet, 2011, 25.8 million people in the US (8.3% of the population) had 
diabetes  in 2010 [6].  The role of skeletal muscle in the development of insulin resistance and 
T2D has been studied extensively.  Skeletal muscle plays a large role in glucose and fatty acid 
oxidation.  Skeletal muscle dysfunction may cause improper fuel usage (oxidation), which may 
contribute to T2D.  This review will focus on one form of skeletal muscle dysfunction, referred 
to as “metabolic inflexibility”; how it develops and how it relates to obesity and T2D.  Factors 
that may contribute to the development of metabolic inflexibility, such as diet, physical activity, 




 “Metabolic flexibility” (MF) is a term that has only been recently developed and is most 
commonly examined in relation to T2D.  Most studies involve evaluating how MF differs among 
various populations (lean, obese nondiabetics, and obese diabetics) with the intention of 
determining if changes in MF develop prior to or along with the development of T2D.  Many 
researchers have defined MF as the change in respiratory quotient (ΔRQ; insulin-stimulated RQ 
– fasting RQ) [7-11].  In one recent study, MF was defined as the change in non-protein RQ 
(∆NPRQ) at the end of a refeeding diet period compared to the end of a caloric restriction diet 
period [12].  However, some authors don’t explicitly calculate ΔRQ, but still use the 
terminology.    For example, Prior et al. looked at the changes in RQ from a fasted state to 
various low intensity exercise sessions which they considered “metabolic flexibility during 
exercise” [13].  Others look at how subjects adapt their fat oxidation to a high fat diet and 
consider this metabolic flexibility [14, 15].  Bergouignan at al. [16] has also pointed out the 
variety of MF definitions and came up with another way to measure MF – by the variance of 
NPRQ and the variance of insulin.  At this point, there has not been enough research done to 
develop a quantitative index of metabolic flexibility.  There may be ΔRQ values that are 
significantly different between the previously mentioned populations, but the numbers don’t 
mean anything yet.  A “normal” range hasn’t been identified, nor has a value or range that could 
indicate an increased risk for developing T2D, etc.  Therefore, this literature review will take the 
reader through the developing research on MF, which may potentially lead to a quantitative 
index.   
 To begin, it is essential to understand what MF means in terms of appropriate fuel usage.  
This means being able to switch fuel sources so that fat is used when in a fasted state and 




utilization by measuring RQ, which also increases with exercise.  Multiple factors contribute to 
the way the body handles fuel.  These include the secretion of insulin by the β-cells of the 
pancreas and the functionality of skeletal muscle.  Insulin and amylin control glucose levels in 
the body, while smaller mitochondria or the amount of lipid in the skeletal muscle can affect the 
ability of the skeletal muscle to use the fuel that it obtains.  Another topic that will be addressed 
is whether this inflexibility is an intrinsic factor in the skeletal muscle cells (myotubes) as 
opposed to something that develops over time as someone becomes obese or insulin resistant. By 
understanding these metabolic and tissue factors, the reader can better comprehend the MF 
research that is presented.   
1.1.2 Overview 
 
MF research spans a variety of topics; therefore, this literature review is arranged by 
these topics to aid the reader in navigating this document.  Initially, correlations will be 
introduced in order to see how MF relates to the characteristics of the populations evaluated, 
especially body mass index (BMI), body fat, aerobic capacity (VO2max), and insulin sensitivity.  
Since metabolic inflexibility seems to be related to T2D, populations with a family history of 
T2D will be examined to see whether or not this inflexibility is seen prior to the development of 
T2D.    Next, gender and race differences in MF will be briefly discussed, since disease risks 
vary between men and women and among different ethnicities.   Recently, some researchers have 
been examining MF in subjects with various conditions other than T2D, such as subjects with 
multiple sclerosis.  Finally, environmental factors such as diet and exercise will be considered.  
Metabolic inflexibility demonstrates inefficient fuel usage, so diets of various macronutrient 




adjusted to the type of diet.  Exercise could potentially be part of the solution for metabolic 
inflexibility if it results in weight loss and better insulin sensitivity. 
1.2 Metabolic Factors 
1.2.1 Substrate Utilization 
    RQ is the ratio of the volume of CO2 expired to the volume of O2 consumed 
(VCO2/VO2), which reflects substrate oxidation.  For example, RQs of 1.000, 0.710, and 0.835 
would indicate exclusive carbohydrate, fat, and protein oxidation respectively [17].  RQ is 
commonly used interchangeably with respiratory exchange ratio (RER).  However, RER is the 
ratio of VCO2/VO2 measured from expired gases and RQ is the ratio of VCO2/VO2 for cells [18].  
It is thought that RER reflects ongoing cellular processes [18].     
Fuel usage among various populations, including lean, obese, and diabetics, have been 
evaluated in many studies.  Blood samples (arterial and femoral venous) drawn from the leg of 
obese and lean subjects to measure the O2 and CO2 content in the blood were compared [19].  
Obese subjects had significantly higher fasting leg respiratory quotients (RQs) than those of lean 
subjects (0.90±0.01 vs. 0.83±0.02, means ± SE) [19].  This higher fasting RQ suggests that obese 
subjects use less fat as an energy source.  Lean subjects had significantly higher insulin-
stimulated leg RQs, indicating that they are using carbohydrates (glucose) for energy and at the 
same time suppressing fat oxidation [19].  This pattern of fuel usage (oxidation) was confirmed 
when total substrate oxidation was calculated using indirect calorimetry equations along with 
VO2 and VCO2 as variables [19].  In addition, Type 2 diabetics have been shown to have reduced 
uptake of free fatty acids (FFA), higher leg RQ, and lower lipid oxidation than nondiabetics 
during fasting [20].  After insulin stimulation, FFA uptake was not significantly different than in 




glucose oxidation, and their leg RQ remained higher than the nondiabetics after insulin 
stimulation [20].  This demonstrates that diabetics in a fasted state were not using fat, and in a 
fed state, glucose oxidation was not suppressing FFA uptake as much.  This impairment in fat 
oxidation observed in obese subjects and Type 2 diabetics has suggested a new potential marker 
in the development of IR and T2D: metabolic flexibility (MF).   
MF is the ability to switch fuel sources based on substrate availability.  For example, 
using fat while in a fasted state and carbohydrates during insulin stimulation is an indicator of 
being metabolically flexible.  The phrase “metabolic flexibility” was created by Kelley and 
Mandarino [21] and is specifically defined as “the capacity to switch from predominantly lipid 
oxidation and high rates of fatty acid uptake during fasting conditions to the suppression of lipid 
oxidation and increased glucose uptake, oxidation, and storage under insulin-stimulated 
conditions.”  One author compared metabolic inflexibility to gridlock that might be experienced 
during rush hour traffic [22].  Chronic overeating would cause gridlock in the mitochondria with 
the excess fuel resulting in substrate competition and unclear signals regarding which substrate 
to use [22].  Appendix A provides a summary of important studies related to MF and is 
organized by the year published. 
1.2.2 Insulin 
Insulin has been well established as a pancreatic hormone that contributes to the 
regulation of intake by acting as an adiposity signal [23].  Type 2 diabetes (insulin resistance) 
interferes with intake regulation [23].  When food is consumed, insulin is released from the β-
cells of the pancreas in order to control blood glucose level by promoting the uptake of glucose 
by skeletal muscle [24].  In a fed state, gluconeogenesis is inhibited and glycogenesis occurs in 




fatty acid synthesis [24].  Individuals with Type 2 diabetes are insulin resistant and are less 
efficient in controlling blood glucose.  FFA release is not inhibited in adipose tissue, and glucose 
uptake is not stimulated by the skeletal muscle because of the resistance to the release of insulin 
[24].  Blood glucose levels remain elevated, which causes the release of more insulin in an 
attempt to control glucose levels, and FFA levels are elevated as well [24].  Kelley et al. [25] 
examined healthy subjects with no history of T2D during “physiological hyperinsulinemia and 
euglycemia.”  Under those conditions, glucose is primarily oxidized in skeletal muscle, while 
lipid oxidation is suppressed.    The leg RQ also demonstrates the increase in glucose oxidation 
with a hyperinsulinemic value of close to 1 (0.99±0.02, means ± SE) compared to the basal value 
of 0.74±0.02 which would be representative of increased lipid oxidation.  This response 
demonstrates appropriate fuel usage by skeletal muscle.  It bears repeating that this ability of 
skeletal muscle to change substrate use is a key characteristic of “metabolic flexibility.”   
1.2.3 Calorimetry  
Indirect room calorimetry is a way to measure MF, since it provides data for the 
calculation of RQ (see next paragraph).  Energy expenditure and substrate use can also be 
calculated.  Unlike a direct calorimeter, an indirect calorimeter does not involve measuring heat 
production.  Typically room calorimeters are approximately 9’x12’ and each are equipped with a 
bed, desk, computer, TV, DVD player, phone, radio, treadmill, and bathroom facilities (Figure 
1.1).  Further descriptions are provided in Rumpler et al. [26] and Seale et al. [27].  Subjects 
usually remain in the room for approximately 23.5 hours.  They receive their standardized meals 
through an airlock in the door, and an arm port in the window allows them to have their blood 




go to bed, wake up, eat, and perform any activities involved in the study (exercise, blood draws, 




Figure 1.1: Room calorimeter 
The exterior (a) and interior (b) of the respiratory calorimeters at the USDA Beltsville Human Nutrition Research 
Center. 
Figure 1.2: Study participant 
Subject running on the treadmill in the 





Calorimetry involves measuring five variables which include: air flow, fractional O2 
inspired, fractional O2 expired, fractional CO2 inspired, and fractional CO2 expired by measuring 
mass and composition (via mass spectroscopy) and volume (via mass flow) of air into and out of 
the calorimeter.  From these variables, the volume of O2 (VO2) in L/min, volume of CO2 (VCO2) 
in L/min, and RQ can be calculated.  VO2 and VCO2 would then be multiplied by the duration of 
the calorimeter stay to calculate the total volume of each.  Urinary nitrogen (UN) is also 
measured during the calorimeter session.  From these data, the equations in Livesey et al. [28] 
can be applied to calculate substrate oxidation and total energy expenditure.  In addition, 
substrate balances can be determined using the dietary intake and substrate oxidation data.   
Ideally, observations of the changes in substrate oxidation rates would be made nearly 
instantaneously allowing for the assignment of these changes to subtle differences in the 
conditions (food intake, physical activity, etc.) impacting the individual in the calorimeter.  
However, variability in the collected calorimeter data is a function of both the volunteer (signal) 
and the instrumentation (noise).  Assuming that the noise is random, averaging of the data over 
extended periods of time minimizes the effect of the noise.  However, averaging the data 
obscures the short term changes and rapidly occurring responses of the volunteer in the 
calorimeter.  The USDA Food Components and Health Laboratory recently published a method 
[29] using data collected while the calorimeters were empty and while a known amount of 
ethanol was combusted to characterize the “noise” inherent in the system.  Estimates of the 
“noise” are included in the algorithms used to calculate the variability in the O2 consumption and 
CO2 production to improve the estimate of the variability from the volunteer. The method 
dampens the noise and simultaneously smoothes the room calorimeter data using regularized 




several minutes [29].  This means that variations in RQ, O2 consumption, and CO2 production 
are observed immediately after meals or exercise, and the rate at which a subject switches fuel 
sources after an event is estimated, thus allowing a new insight into the data.    For example, after 
a high carbohydrate meal, a subject’s RQ should increase to reflect use of carbohydrates for 
energy, and it typically would increase almost simultaneously with VO2 (energy expenditure).  
During exercise, some subjects have demonstrated a lag in how quickly their RQ adjusts when 
compared to VO2.  In some cases, the RQ peaks after the VO2 is returning to baseline.  This lag 
is illustrated in Figure 1.3 where after the exercise period (around 1200 min elapsed time), the 
peak in RQ occurs after the VO2 peak.  Using cross-correlation, RQ and VO2 can be compared, 
and the maximum of the cross-correlation function is defined as the lag and is measured in 
minutes.  Lag has been shown to be positively correlated to age (Figure 1.4).  It has also been 
verified using alcohol control trials that this new method allows observation of the changes due 
to physiological responses independent of calorimeter instrumentation noise (unpublished data).  
Alcohol has an RQ of 0.667 [17] when combusted.  Combusting alcohol in the 
calorimeter allows for the characterization of the variation in O2 and CO2 composition under 
controlled conditions which can then be compared to the variation observed when subjects are 
present in the calorimeters.    Using this new biomarker, factors that cause the variations in the 
lag times can be examined.  A recent examination of the calorimeter data at the USDA has 
identified other potential variables that might be worth considering including the slope of RQ.   
Analyzing variables such as lag time or the slope of RQ could provide valuable information to 
quantify an index of MF using just room calorimetry [30].  With the calorimeter data collected, 
MF (ΔRQ) can still be calculated in a manner similar to the literature by taking the average RQ 






Figure 1.3: Subject lag following exercise 
Example of a subject demonstrating a lag in RQ after an exercise period (the largest 
VO2 peak).  (Presented at NFSC Research Day) [31] 
Figure 1.4: Average lag time vs. age 
In a study of healthy adult males, ages 47-65 (BMI: 24.6 – 31.2), there was a 
positive correlation between the subjects’ average lag time following exercise and 





1.3 Tissue Factors 
1.3.1   Skeletal Muscle Mitochondria  
In addition to the role of insulin, several investigators have evaluated skeletal muscle, 
focusing on the question: “Does impaired fat oxidation contribute to the development of IR and 
T2D?”  These studies examine skeletal muscle mitochondria, lipid content of skeletal muscle, 
and skeletal muscle cells.  Skeletal muscle mitochondria are smaller or damaged in obese and 
Type 2 diabetic subjects compared to lean subjects, and the size correlates positively with insulin 
sensitivity (IS), as measured by glucose disposal rate (GDR) [32]. Smaller muscle mitochondria 
may result in the mitochondria not performing to their full capacity in terms of generating energy 
from available sources. For example, small or damaged mitochondria results in less β-oxidation 
converting fat to energy.  The capacity of the oxidative and glycolytic enzymes in skeletal 
muscle is also important to consider when examining the energy capability of the muscle.  In a 
group of 17 women, low Hounsfield attenuation muscle was negatively correlated to citrate 
synthase (CS) activity (aerobic-oxidative capacity) and positively correlated with both creatine 
kinase (CK) activity (anaerobic capacity) and glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) activity (glycolytic capacity).  The ratio of phosphofructokinase to citrate synthase 
(PFK/CS) was also positively correlated to low attenuation muscle demonstrating that there is 
more glycolytic capacity as the area of low attenuation muscle increases. [33].  Attenuation was 
determined by a computed tomography (CT) scan, where normal attenuation muscle was 
measured from 35-100 Hounsfield units (HU) and low attenuation muscle was measured from 0-
34 HU [33].  Based on the Hounsfield scale where the reference is water (0 HU), muscle has a 




attenuation muscle, and area of muscle with low attenuation was negatively correlated to rates of 
leg glucose storage [33].  Using step-wise multiple regression, the authors found that 57% of the 
variance in leg glucose storage was accounted for by low attenuation muscle and visceral 
adiposity, with low attenuation muscle having the strongest predictive value for insulin 
resistance [33]. 
1.3.2 Skeletal Muscle IMCL 
Intramyocellular lipid (IMCL) content in skeletal muscle was negatively correlated to 
insulin action at the low dose of insulin infusion during the clamp for a group of nondiabetic 
male Pima Indians, but was not significantly correlated with BMI, percent body fat, or waist-to-
hip ratio [35].  IMCL also tends to be higher in obesity [36].  It has been suggested that the cause 
of this increase is due to the regulation of fat oxidation being “inflexible,” and this deregulation 
is associated to IR [19].  In healthy, normal weight men and women, IMCL is negatively 
correlated with M-value (whole body glucose uptake) during insulin stimulation [37].  The 
authors concluded that IMCL, which they measured via 1H NMR spectroscopy, is a good 
predictor of IS.  IMCL was higher in offspring of type 2 diabetic parents compared to controls, 
but there was no correlation between IMCL in either the tibialis anterior or soleus and fasting 
lipid oxidation in either group [38].  Lipid content and oxidative enzyme capacity has been 
examined by fiber type as well [39, 40].  Type 2 diabetics and obese subjects had a significantly 
higher lipid content and a significantly lower oxidative enzyme activity in each muscle fiber type 
(type 1, type IIa, and type IIb).   He et al. [39] also found that muscle glycogen was lower in 
Type 2 diabetics and negatively correlated with hyperglycemia, suggesting a negative correlation 




Curiously, endurance athletes have more IMCL, but still remain insulin sensitive.  
Goodpaster et al. [41] found that endurance-trained athletes had more IMCL than did lean 
subjects, and trained subjects had a higher oxidative capacity in their muscle compared to lean, 
obese nondiabetics, and obese diabetics.  In addition, lean and trained subjects were more insulin 
sensitive than both obese groups.  After 16 weeks of moderate exercise training, older, obese 
men and women had an increase in IMCL, insulin sensitivity, oxidative capacity, and glycogen 
content and a decrease in diacylglycerol and ceramide [42].  In a group of healthy older adults, 
IMCL and oxidative capacity of the muscle both increased after participation in 12 weeks of 
exercise training [43].  Exercise-induced fat oxidation increased.  Trained subjects seem to show 
a better ability to use the fat that is in their muscle, so that they don’t become insulin resistant.   
Although obese, sedentary men and women who participated in a weight loss and 
physical activity intervention did not have a significant change in their IMCL content, they did 
have a significant decrease in lipid droplet size.   The change in size of the droplets was 
negatively correlated to the change in IS; thus, the more the size decreased, the more IS 
improved [44].  Using succinate dehydrogenase staining, there was an increase in oxidative 
enzyme capacity after this intervention.  When reexamining biopsy samples from a previous 
study, the authors found that the lipid droplets were larger in Type 2 diabetic subjects compared 
to those from lean subjects who were nondiabetics and sedentary.  Lipid droplets from obese 
subjects who were also nondiabetic and sedentary were similar in size to those from Type 2 
diabetics.  Lipid droplet size seems to also play a role in the development of insulin resistance, 
but it appears to be how the lipid is dispersed that matters and not necessarily the amount of fat.  




1.3.3 Skeletal Muscle Cells  
Another question that needs to be addressed is whether or not this inflexibility is an 
intrinsic factor in the skeletal muscle or is it something that develops over time as someone 
becomes obese or insulin resistant.  When examining myotubes, or muscle cells, from lean, 
obese, and obese Type 2 diabetics, it was found that glucose oxidation and palmitate oxidation 
were insulin-sensitive for all groups [45].  Myotubes from all groups remained insulin-sensitive 
even after supplementation with palmitate reduced basal and insulin-stimulated glucose 
oxidation.  This led to the conclusion that metabolic inflexibility was not an intrinsic defect but 
an extramuscular mechanism, meaning that some outside issue was contributing to skeletal 
muscle performance in these groups.  By contrast, Ukropcova et al. [46] found that metabolic 
switching, defined as the changes in fat oxidation in muscle cells, reflects the metabolic 
characteristics of the donor.  It would be expected that someone who is metabolically flexible 
would be efficient in their metabolic switching both in vivo and in vitro.  This would suggest that 
if the donor was metabolically flexible, their myotubes would be metabolically flexible as well.  
As anticipated, in the absence of insulin, suppression of fat oxidation by glucose in the myotubes 
(suppressibility) was negatively correlated with MF and IS and positively correlated with body 
fat and fasting FFA levels [46].  The ability of the myotubes to increase fat oxidation 
(adaptability) was positively correlated with MF, IS, and aerobic capacity and negatively 
correlated with % body fat and fasting insulin levels [46].  Delta RQ was not determined in the 
myotubes. 
The result is that there is a disagreement in whether MF is an intrinsic defect or an 
extrinsic defect in skeletal muscle.  However, MF of the subjects was not actually measured in 




determining factor.  It would have been interesting to identify which subjects were metabolically 
flexible to better compare the subject to the myotubes.  In addition, establishing whether or not 
myotubes were insulin-sensitive does not give the whole picture.  These myotubes were judged 
by whether insulin-stimulated glucose or fat oxidation was significantly different from basal, and 
all three groups were.  However, Type 2 diabetics had significantly higher basal and insulin-
stimulated glucose oxidation than leans suggesting that the myotubes may be insulin-sensitive, 
but their response is altered [45].     
Hessvik et al. [47] also evaluated myotubes, but pretreated them with the liver X receptor 
(LXR) agonist T0901317 and different fatty acids.  In addition to looking at suppressibility and 
adaptability, they looked at a new parameter that they called: substrate-regulated flexibility.  This 
parameter was defined as “the ability of the myotubes to increase the acute fatty acid oxidation 
while changing from a ‘fed’ (low fatty acid and high glucose concentration) to a ‘fasted’ 
condition (high fatty acid and no glucose added).”  Pretreatment with eicosapentaenoic acid 
(EPA) increased the suppressibility of the cells.  Adaptability was significantly increased by 
pretreatment with EPA, linoleic acid (LA), and palmitic acid (PA).  EPA, along with LA and PA, 
increased substrate-regulated flexibility.  It was also found that EPA regulated the most genes of 
the fatty acids, and that myotubes that were exposed to EPA had stimulation of carbohydrate 
metabolism pathways.  The conclusion was that n-3 fatty acids may improve metabolic switching 
in skeletal muscle [47].  These samples were taken from eight healthy subjects with no family 
history of diabetes.  More research is needed to examine whether this could provide 
improvement to the myotubes of obese or Type 2 diabetic subjects.   
Myotubes from healthy subjects were examined to see the effect of chronic 




that were placed in a state of chronic hyperglycemia when compared to the normoglycemic cells; 
however, there was no difference between the cells in adaptability.  After hyperglycemia, 
glucose oxidation was reduced, but mitochondrial DNA was not different between groups.   
Expression of mitochondrial enzymes involved in substrate switching were also 
examined from skeletal muscle of subjects with normal glucose tolerance or T2D [49].  The 
enzymes included in the evaluation were pyruvate dehydrogenase kinase (PDK) 4, PDK2, 
malonyl-coenzyme A decarboxylase (MCD1), and carnitine palmitoyltransferase 1b (CPT1b).  
Subjects with T2D had an increased messenger RNA (mRNA) expression of PDK4, PDK2, and 
MCD1.  Some subjects underwent a 4 month intervention which involved increasing weekly 
physical activity by 5 hours of Nordic walking.  Messenger RNA expression of PDK4 increased 
only in the normal glucose tolerant subjects; however, the exercise was not monitored.   
Another study examined mitochondrial respiration in human skeletal muscle cells to see the 
response to changes in substrate availability in obese versus lean subjects [50].  There was a 
large increase in mitochondrial respiration (state 3) after 24 hour lipid incubation in the lean 
cells, and this was not seen in the obese cells.  In addition, mtDNA copy number increased in the 
lean cells after the incubation, while the mtDNA copy number deceased in the obese cells.  With 
all these studies, it would beneficial to evaluate the metabolic flexibility of the actual subjects for 
comparison to their skeletal muscle cells.    These factors discussed in the previous sections have 
the potential to affect fuel usage in the body.  Insulin affects the glucose levels in the body, and 
the skeletal muscle must be fully functional to be able to use the fuel efficiently.  Therefore, 




1.3.4 MF Correlations 
Due to the trend of increasing obesity which can lead to an increased risk for IR and T2D, 
it is worthwhile to evaluate the relationships between MF, obesity, and diabetes risk.  It is also 
necessary to identify who may develop this inflexibility and what the contributing factors are.  
Important variables to consider for these health problems include percent body fat, body mass 
index (BMI), insulin sensitivity (IS), and aerobic capacity (VO2max).  It has been reported that 
IS, which is commonly measured in terms of glucose disposal rate (GDR), is negatively 
correlated with BMI, fat mass, % body fat, and visceral fat in young, healthy men with or 
without a family history of T2D [8, 46].  These correlations are not surprising, since it is well 
established that obese individuals are more likely to become insulin resistant.  Young, healthy 
men have a positive correlation between IS and both VO2max and mitochondrial DNA [8].  
Physical activity is known to increase IS; therefore, a positive correlation is expected.  MF is 
inversely correlated with body fat and FFA levels and positively correlated with IS, VO2max, and 
mitochondrial DNA in the above population [8, 46]. The correlations between MF and both IS 
(determined by glucose disposal rate) and FFA levels were also confirmed in a population of 
obese men and women, with or without T2D [10].  In this study, Type 2 diabetics had a 
significantly lower metabolic flexibility than obese nondiabetics; however, there was no 
difference after adjusting for GDR [10].  Another evaluation was done by dividing MF into 
quartiles for comparison purposes, and it identified the lowest quartile as being associated with 
larger fat cells, higher % body fat, and lower serum adiponectin levels [51].  Adamska et al. [52] 
also identified a positive correlation between adiponectin and MF as well as a negative 
correlation between both sTNFR1 and sTNFR2 (soluble TNF-α receptors) and MF in a group of 




positively correlated to IS, and higher in nondiabetics than Type 2 diabetics in a population of 
men and women of various race, age, BMI, and diabetes status [11].  These studies demonstrate 
that an individual is more likely to have this inflexibility if they have a high level of body fat 
(obese) and are insulin resistant.  It is not surprising that MF decreases as people age, since there 
is a tendency to lose muscle mass and many people become less active for reasons such as health 
conditions.  In a study of men and women of various insulin sensitivities, MF was significantly 
lower in the insulin resistant-non diabetic group (BMI: 28 kg/m2 or higher) and the Type 2 
diabetic group when compared to the insulin sensitive-lean control group [53].  The significantly 
lower MF in T2D subjects compared to controls was also seen in a study of obese men [54].  
This study also determined that whole body glucose disposal predicts MF and insulin-stimulated 
RER, and mitochondrial function predicts basal RER.  Obese adolescents with IR have a 
significantly lower MF than obese adolescents that are insulin sensitive [55].  A positive 
correlation was found between intermyofibrillar mitochondria content and MF, but there was no 
correlation between subsarcolemmal mitochondria content and MF [53]. Reduced ability to 
switch fuel sources has also been reported in obese men with impaired glucose tolerance, a 
prediabetic state [56].  Perhaps this inflexibility could be an early factor or marker in the 
development of T2D [56].  However, it remains unknown as to whether or not the inflexibility 
developed before or after these conditions and if family history plays any role.  When examining 
men and women in two different prediabetic states, isolated impaired fasting glycemia (i-IFG) 
and isolated impaired glucose tolerance (i-IGT), MF was significantly lower in both groups when 
comparing them to the normal glucose tolerance (NGT) group [57].  This remained true after 
adjusting for insulin sensitivity and BMI.  The authors think that the inflexibility may precede 




performed.  Soluble E-selectin (sE-selectin), a marker of endothelial dysfunction, was found to 
be negatively correlated to both MF and insulin sensitivity in a group of lean and obese women 
with normal glucose function [58].  Metabolic syndrome total Z-score was also negatively 
correlated to MF and insulin sensitivity and positively correlated to sE-selectin.  The authors 
suggest that maybe the endothelial dysfunction leads to MF (improper fuel usage) and then 
insulin resistance follows. 
 
1.4 Genetic, Gender, and Racial Factors 
1.4.1 Family History 
 
Family history of T2D may be a factor in the development of metabolic inflexibility.  
This idea has been evaluated in two feeding studies and one that involved passive stretching and 
a glucose load.  There is a trend towards decreased MF in subjects with a family history of T2D 
and a decrease in mitochondrial DNA [8].  Mitochondrial DNA (mtDNA) content correlated 
inversely with sleep RQ during a high fat diet and positively with MF and IS.  MtDNA content 
was also negatively correlated with BMI and body fatness and positively correlated with VO2max 
[8].  This decrease in mitochondrial DNA may not allow the generation of enough energy to 
enable efficient substrate switching, and it is another factor related to obesity and a more 
sedentary lifestyle.  After a high carbohydrate meal, serum insulin tended to be increased in 
subjects with a family history of T2D, but they were not significantly different from the controls 
in regards to their RQs [59].  After a high fat meal, subjects with a family history of T2D had a 
diminished capacity to reduce RQ compared to controls, suggesting an impaired ability to switch 




with a family history of T2D had a significantly higher sleep RQ on the third day, which 
indicated a reduction in fat oxidation [8].  Sleep RQ measured when subjects were fed a high fat 
diet was also inversely related to MF, suggesting that subjects with a family history of T2D were 
already showing early signs of metabolic inflexibility [8].  Russell et al, used hood calorimetry to 
evaluate RER when subjects were passively stretched and consumed a glucose load [60].  
Subjects had a 10 minute break from the hood after the stretching session.  This is when the 
glucose load was consumed, and they returned to the hood.  The subjects included controls, 
subjects with a family history of T2D, and subjects with T2D.  Passive stretching increased 
carbohydrate use for all groups with a significantly greater CHO rate change for the subjects 
with T2D compared to the controls.  There were no differences between groups in ΔRER during 
the stretching.  The controls were more metabolically flexible than the subjects with T2D and the 
subjects with a family history of T2D.  This was observed both in ΔRER AUC and the ΔRER at 
15 minute intervals (up to 1 hour).  There were no differences in MF between the subjects with a 
family history of T2D and the subjects with T2D.  Taken together, these studies show that a 
genetic factor in skeletal muscle could predispose individuals to develop this inflexibility.  
However, two of the above studies do not clearly define how many of the subjects with a family 
history of T2D were already overweight or obese, a state which would increase their disease risk 
even without the history.  Russell et al. [60] required that the control subjects and the subjects 
with a family history of T2D had a BMI in the normal range.  The subjects with T2D had BMIs 
in the overweight range and were significantly older than the other groups.  In addition, subjects 
with a family history of T2D had a significantly different response of the genes PGC1α 




translocase) to a high fat meal [59].  A high fat meal upregulates PGC1α and FAT/CD36 in lean 




When examining gender differences in healthy, young subjects, it has been determined 
that women had higher MF than men, even though they had significantly more body fat than the 
men [9].  This may be surprising due to the negative correlation found between % body fat and 
MF as mentioned previously in a population of men.  It would seem that women should be less 
flexible.  We speculate that it is the distribution of the fat that may be more important.  Visceral 
adipose tissue mass was negatively correlated with MF for both the women and men, and women 
had less [9].  In addition, fat cell size was not significantly different between the groups, again 
suggesting that it is not how much fat, but how it is distributed that influences MF.  Fasting and 
insulin-suppressed non-esterified fatty acids differed between men and women; women had 
significantly higher fasting non-esterified fatty acids (NEFAs) than men but had significantly 
lower insulin-suppressed NEFAs than men [9].  MF was negatively correlated with insulin-
suppressed NEFAs.  Adiponectin levels were higher in women than men, and adiponectin was 
positively correlated with MF in men; however, the correlation was not significant in women.  
Women also had a higher expression of the genes involved in adipogenesis (peroxisome 
proliferator-activated receptor- γ2, PPARγ2), lipid storage (phosphoenolpyruvate carboxykinase 
1, PCK1 and stearoyl-Coenzyme A desaturase 1, SCD1), and lipid oxidation (peroxisome 
proliferator-activated receptor-α, PPARα).  Sparks et al. [9] suggests that adipose tissue 




no differences in macrophage content markers, expression of chemokines, or classic 
inflammatory pathway (M1).  However, women had a significantly higher anti-inflammatory 
pathway (M2) marker leading to the hypothesis that higher MF in women could be due to their 
macrophages being predominantly activated along an anti-inflammatory pathway [9].  In 
addition, each gender only had two adipose tissue factors that correlated with MF.  For women, 
they were SCD1 and PCK1 mRNA, and for men they were serum adiponectin and insulin-
suppressed NEFAs.  Also, men and women both demonstrate a positive correlation between 
intermyofibrillar mitochondria content and MF [53]. 
1.4.3 Race 
 
Due to the prevalence of obesity being higher in African Americans, and African 
Americans being at high risk for T2D [6], does this also mean that they are metabolically 
inflexible?  Berk et al. [61] found that Caucasian women had significantly higher fat oxidation 
during a high fat diet and higher carbohydrate oxidation during the low fat diet, whereas African 
American women had no significant differences.  However, Stull et al. [11] reported that MF was 
greater in African American men and women compared to Caucasian men and women and 
remained greater after adjusting for IS, diabetes status, triglyceride concentrations, and fasting 
RQ.  Adjusting for diabetes status was important due to the unbalanced number of African 
Americans (n=19; 4 men, 15 women) and Caucasians (n= 60; 35 men, 25 women) with T2D.  
Delta carbohydrate oxidation was not different between the races, but Δ fat oxidation was 
significantly higher in African Americans than Caucasians even after adjusting for IS, diabetes 
status, fasting triglyceride concentrations, and fasting fat oxidation [11].  These studies gave 




women and did not actually measure MF (ΔRQ).  Instead, fat and carbohydrate oxidation was 
examined to determine if there was an impaired ability to switch substrate use.  The comparison 
of the articles would have been more interesting if they both measured (MF), or if Stull et al. [11] 
considered comparing the role of race in men and women separately as well.  
Another study examined South Asians due to their high T2D risk compared to Europeans 
[62].  Middle-aged men with a family history of T2D consumed a very low calorie diet for 8 
days.  After the 8 days, the shift from glucose oxidation to lipid oxidation was significantly less 
for the South Asian men than the European men.  Based on MF in terms of fat oxidation rates, 
the South Asian men were less flexible when adapting to the diet.    
1.4.4 Medical Conditions 
 
Metabolic flexibility of subjects with various medical conditions (other than T2D or IR) 
has been reviewed recently. .  In a study of men with (n=11) or without (n=11) Type 1 diabetes 
(T1D),  men with T1D had a significantly lower basal RQ and a significantly lower MF than the 
controls [63].  During the clamp, the subjects with T1D had a significantly higher lipid oxidation 
rate throughout the clamp and a significantly lower carbohydrate oxidation rate during periods I 
and II of the clamp when compared to the controls.  When evaluating 16 subjects with Multiple 
Sclerosis (MS) and 16 control subjects, the MS subjects had a higher MF than the controls [64].  
The higher RQ after the glucose load is indicative of a higher carbohydrate oxidation rate.  When 
receiving the oral glucose load immediately prior to exercise, the MS subjects increased their RQ 
to a higher level than the controls, demonstrating that they were using more carbohydrates.  
However, the MS subjects had a sharp decline in RQ after 20 minutes of exercise and continued 




with anorexia nervosa and controls [65].  There were conflicting results in two studies involving 
women with polycystic ovary syndrome (PCOS).  In one study involving lean and obese women 
with or without PCOS, it was found that there was no difference in MF between the subjects with 
PCOS and the controls; however, MF of the obese subjects (with or without PCOS) was 
significantly lower than the lean subjects [66].  It was further reported that women with PCOS 
had a significantly lower MF than data previously obtained from healthy women [67].  Normo-
androgenemic PCOS women had a significantly higher MF than hyper-androgenemic PCOS 
women.  For this group of women, MF was positively correlated with glucose disposal rate and 
negatively correlated with BMI, free testosterone, fasting insulin, and baseline RQ.  A possible 
reason for this variation in results is that there were more PCOS subjects in first article that were 
lean with a BMI in the normal range (21.4 ± 2.0 kg/m2, mean ± SD; 40 out of 92 total PCOS 
subjects vs. 24 out of 89 PCOS subjects).  PCOS women were also found to use less lipid during 
an overnight fast compared to women without PCOS [68]. 
 MF has also been examined in obese adolescents with and without non-alcoholic fatty 
liver disease (NAFLD) [69].  The adolescents with NAFLD had a significantly higher fasting RQ 
than the ones without the disease.  Both groups had a significant increase in RQ from fasting to 
insulin-stimulated; however, the adolescents without the disease had a significantly higher MF 
that the adolescents with NAFLD.  This significantly higher MF in adolescents without NAFLD 
was also shown by Perseghin et al.[70] The authors also found that the adolescents with NAFLD 





1.5 Environmental Factors 
1.5.1 Diet 
 
There have been a variety of metabolic flexibility studies that have related to diet.  Diet 
composition does not have an effect on daily energy expenditure, but daily substrate oxidation 
shifts so that it is closer to matching substrate intake [71].  This means that a person will use the 
same amount of energy (kcals) no matter what the diet composition is, but the percentage of 
kcals from each substrate changes with the composition.  For example, a high fat intake will 
result in a shift toward increased fat oxidation, or a higher percentage of daily energy from fat.  
High fat diets promote positive fat and protein balances and a negative carbohydrate balance is 
achieved [72].  Fasting insulin was found to be positively correlated to fat balance over the four 
days on a high-fat diet, and VO2max and carbohydrate balance were negatively correlated to fat 
balance [72].  When shifted to a high fat diet, physical activity improved fat oxidation in young, 
healthy men [73].  Fat balance (intake – oxidation) over the four days was lower during high 
activity.  In comparison, carbohydrate and protein balances were higher during high activity. 
In addition to analyzing the role of family history, Ukropcova et al.’s [8] diet study 
identified that during a 3-day high fat diet, sleep RQ was negatively correlated with MF and 
positively correlated with VO2max.  Fat balance over the three days was positively correlated 
with sleep RQ and 24-h RQ data from day three.  These findings demonstrate that subjects 
accumulated more fat when they had reduced fat oxidation and therefore a higher 24-h RQ, 
resulting in impaired switching and an inability to match oxidation to intake [8].  After the high 
fat diet, mtDNA was positively correlated with plasma adiponectin.  Plasma adiponectin levels 




correlated with MF [8]; therefore, the positive correlation between mtDNA and adiponectin is 
not surprising. 
When on a high fat diet for 3 weeks, overweight men had a decrease in MF and an 
increase in intrahepatic lipid (IHL) content when compared to their low fat diet counterparts 
[75].  Insulin sensitivity and IMCL were not affected by the diet.  Fat oxidation was significantly 
increased in the high fat group during the clamp which demonstrates a decrease in MF; however, 
the authors indicate that this could just be the result of the body adapting to the high fat diet.   
After one high fat meal, a group of healthy, lean men and women had an increase in 
mRNA content of peroxisome proliferator activated receptor α (PPAR-α) whereas the obese, 
insulin resistant men and women did not [76].  After continuing on the high fat diet for 5 days, 
mRNA content for various genes involved in lipid oxidation (PPAR-α, pyruvate dehydrogenase 
kinase 4, PPAR γ coactivator-1α, and uncoupling protein 3) increase in lean, but decreased in the 
obese subjects.  The authors deemed the ability to up-regulate these lipid oxidation genes in 
response to a high fat diet as indicative of metabolic flexibility. 
A three month intervention involving obese men and women (65 ± 1 years old, mean ± 
SEM) performing aerobic exercise and consuming either a high or low glycemic diet found that 
metabolic flexibility was significantly improved post intervention for both diet groups [77].  
However, MF was not significantly different between diet groups pre or post intervention. 
The use of salsalate after meals has been examined for improving MF.  Nine healthy 
sedentary men (21.8 ± 1.0 years old, mean ± SE) participated in hyperinsulinemic-euglycemic 
clamp protocols [78].  There were three treatments: control, Intralipid, and Intralipid with 
salsalate.  During the clamps, the control and Intralipid treatments were co-infused with glycerol 




salsalate after meals for 4 days prior to the clamp (4000mg/d), an additional dose of 1500 mg of 
salsalate on the morning of the clamp, and co-infusion of Intralipid during the clamp.  The 
Intralipid infusion was to induce insulin resistance.  It was found that MF was significantly 
reduced in the Intralipid and Intralipid w/salsalate groups compared to the controls.  Intralipid 
w/salsalate group tended to have a higher MF than the Intralipid group, but the difference failed 
to be statistically significant.  However, the carbohydrate oxidation rate during the clamp was 
higher for the Intralipid w/salsalate group compared to the Intralipid group.  There were no 
differences in the density or functioning of the mitochondria taken from muscle fiber sample.  
When overweight men and women were supplemented with epigallocatechin-gallate (E) and 
resveratrol (R) for three days, MF increased compared to the subjects that consumed the placebo 
or E+R+soy isoflavones but only in the men [79].  There was no difference in women.  MF was 
measured as the difference between the highest RQ postprandially and fasting RQ.  The ratio of 
respiratory exchange ratio to food quotient (RER:FQ) while fasted was used as a way to evaluate 
MF with a value greater than 1 indicative of positive fat balance (fat intake>fat oxidation) [80].  
The RER:FQ ratio was not significantly different between the insulin sensitive and insulin 
resistant groups.  Adjusting for age and % body fat resulted in RER:FQ being significantly lower 
in subjects with a family history of T2D compared to no family history, and also significantly 
lower in insulin resistant subjects (homeostasis model assessment (HOMA) ≥ 1.95).  The main 
limitation with this study was that fat intake was assessed using a food frequency questionnaire 
(FFQ). 
Metabolic flexibility has also been defined as an increase in fat oxidation in response to a 
high fat diet.  Lean men significantly increased fatty acid oxidation (measured by complete 




men [14].  Seven days of exercise increased both groups’ fatty acid oxidation compared to pre-
diet; however, adding 3 days of a high fat diet to the exercise did not result in a significant 
increase in fatty acid oxidation.  Also, the lean and obese groups were not significantly different 
after the exercise.  Exercise may have helped the obese group.  Another group examined the 
effects of the infusion of Intralipid during the hyperinsulinemic-euglycemic clamp among lean 
endurance-trained, lean sedentary, and obese sedentary males and females [15].  They 
determined that the trained subjects were more metabolically flexible because they were better 
able to increase their fat oxidation in response to the lipid overload than both the lean and obese 
sedentary subjects.    This highlights how exercise helps with substrate utilization.  
Metabolically inflexible subjects also require more days to adjust their 24-h RQ to a high 
fat or high carbohydrate diet, but eventually they will regulate their 24-h RQ to around the same 
level as their metabolically flexible counterparts [81].  This reveals how inefficient the subjects 
are at switching so that substrate oxidation matches intake even over the course of days. 
1.5.2 Caloric restriction  
 
Another evaluation method was used to determine how 25% caloric restriction affects 
MF [82].  MF was determined by examining the concentration differences in various metabolic 
intermediates between the fasting and postprandial state.  Caloric restriction resulted in 
significantly larger changes in acylcarnitines (AC) over time and trends toward larger changes in 
FFA over time compared to the controls.  The authors determined that this was indicative of an 
increase in MF (AC and FFA concentrations higher during fasting).   
Healthy lean and obese men and women underwent 48 hours of fasting [83].  After 24 




which would be the expected metabolic response to these conditions.  However, the obese 
subjects had a significantly lower increase in fat oxidation and a significantly lower decrease in 
glucose oxidation than the lean subjects, which demonstrates metabolic inflexibility.  This study 
also found that the skeletal muscle of obese subjects had a lower expression of insulin receptor-β 
(IRβ) at baseline, and fasting resulted in a reduction in AMP-activated protein kinase (AMPK) 
activity only in lean subjects.   
   
1.5.3 Exercise 
 
Exercise can improve insulin sensitivity, giving rise to the question: “Can exercise and 
weight loss improve MF as well especially with the positive correlation between IS and MF?”  
Obese men and women without diabetes improved their VO2max and IS after undergoing an 
exercise and calorie reduction weight loss intervention [84].  In addition, their fasting fat 
oxidation rates increased as well as their energy derived from fats.   This change in fat oxidation 
rates demonstrates that these obese subjects were already showing some impaired substrate use 
and possibly impaired substrate switching, but losing weight provided some improvement.  
Obese subjects also showed improvements in IS and suppression of fat oxidation by insulin after 
weight loss, but no change in their fasting leg RQs [19].  In Type 2 diabetics, a 3-month exercise 
protocol increased their whole-body GDR and non-oxidative GDR; however, glucose oxidation 
only tended to increase [85].    In obese men with impaired glucose tolerance (IGT), weight loss 
improved their response to a meal by increasing their forearm muscle RQs [56].  This increase in 
RQ was blunted prior to the weight loss when compared to subjects with normal glucose 




triglycerides only tended to decrease.  After a one-year lifestyle intervention to lose weight via 
increased physical activity and decreased caloric intake, type 2 diabetic subjects experienced an 
increase in both glucose disposal rate and MF to glucose [10].  However, there was no difference 
in MF to glucose before or after the intervention once they controlled for glucose disposal rate.  
A 12-week training program restored MF in obese Type 2 diabetic males to the level of the obese 
controls [7].  This program also improved IS significantly in T2D subjects and improved 
mitochondrial function in both groups, with the T2D subjects returning to control levels.  24 
obese adults underwent a 12 week exercise intervention [86].  An OGTT was performed to group 
them by their prediabetes status: IFG, IGT, and IFG+IGT (n=8 for each group).  MF was 
significantly increased after the intervention in the IFG and IGT groups.  Some of these subjects 
joined additional obese, prediabetic adults to participate in another 12 week exercise intervention 
study [87].  This study also found that after the intervention, MF was significantly improved, and 
MF negatively correlated with fetuin-A, a hepatokine that may be linked to the development of 
T2D.    
Type 2 diabetics who have a dodecanedioic acid (C-12) meal prior to exercise have a 
reduction in muscle fatigue and an increase in lipid oxidation [88].  Insulin secretion is not 
stimulated by C-12.  After the C-12 meal, the amount of glucose oxidized was less and the 
amount of C-12 plus lipids oxidized was more than after the glucose meal.  The authors thought 
that C-12 could potentially restore MF “by reverting the oxidative pathways to a quasi-
physiological condition, as observed in controls.”  However the benefit seems to only extend to 
using C-12 during exercise.  More research is needed to further examine exercise and training 




 As mentioned in the introduction, not all studies measure ΔRQ when discussing 
metabolic flexibility.  For Bergouignan et al. [16, 89], MF is determined by the variance in RQ 
and insulin.  A subject that is metabolically flexible would have a large variance in RQ and a 
small variance in insulin.  Data was combined from two studies to examine the effects of 
physical activity level (PAL) on MF.  The subjects included trained men that detrained for 1 
month, sedentary lean and obese men that trained for 2 months, and active women that 
underwent strict bed rest or strict bed rest with exercise for 2 months.  Increases in PAL resulted 
in an increased MF (decreased insulin variance, increased RQ variance), and PAL was positively 
correlated with RQ variance for all subject groups.  Detraining resulted in a significantly lower 
variance in RQ and a significantly larger variance in insulin, whereas training tended to increase 
RQ variance and decrease insulin variance, but was not statistically significant.   
 MF has also been interpreted as switching to increased fat oxidation during sustained 
exercise [90].  Using this definition, a group of young, normal BMI women were evaluated 
during a 45 min exercise period (at 65% VO2max) by their ratio of abdominal to lower body fat 
[91].  The women with a lower abdominal to lower body ratio had significantly higher fat 
oxidation rates during exercise and therefore a higher MF than the women with a higher ratio.  
There was also a positive correlation between the ratio and lipid oxidation rates.  There was no 
difference at rest.  The women with a higher ratio also had significantly higher RER during 
exercise.   
 Prior et al. evaluated MF when transitioning from fasting/resting to exercise in addition to 
the response when transitioning from fasting to an insulin-stimulated state using 
hyperinsulinemic-euglycemic clamp technique [13].  Overweight/obese subjects (men and 




was determined that 13 had NGT and 10 had IGT.  The IGT subjects had a significantly lower 
MF than NGT subjects during insulin stimulation via the hyperinsulinemic-euglycemic clamp.  
During treadmill exercise at 50% and 60% VO2max, the IGT subjects also had a significantly 
lower MF than NGT subjects.  There was no correlation between the insulin-stimulated MF and 
the exercise MF.  The two groups had similar energy expenditure during the exercise; however, 
the IGT subjects used more fat than the NGT subjects at each intensity.  Once again, metabolic 
inflexibility was present prior to subjects developing T2D.  During the exercise, glucose 
intolerance was negatively correlated with RQ. 
 A different group defined metabolic inflexibility as oxidizing less carbohydrate (using 
more fat) and using less muscle glycogen during exercise [92, 93].  For overweight women 
divided into IS and IR groups, it was found that the IR group used less carbohydrate and less 
muscle glycogen when walking on a treadmill at 45% VO2max than the IS group, but blood 
glucose uptake was not different between the groups [92].  Additionally, during exercise, men 
and women with IFG+IGT used less muscle glycogen and had higher fat oxidation than a group 
of men and women with IGT alone [93].  The IFG+IGT group also had significantly higher 
blood glucose and NEFAs. 
 In summary, various topics related to metabolic flexibility has been addressed, but more 
research is needed to establish a quantitative index or identify a “normal” range.  It would also be 
helpful if a more streamlined definition of how to measure MF is used.  The term has been used 
as a description of many metabolic functions.  We believe that it is time to come to a consensus 








Metabolic flexibility is commonly measured as the change in respiratory 
quotient (RQ) from the fasted state to the insulin-stimulated state.  This measurement 
is performed using a hyperinsulinemic-euglycemic clamp and hood calorimetry. A 
study was performed to evaluate if room calorimetry alone could provide the same 
results and to examine how diet composition and exercise affect metabolic flexibility.  
Sixteen healthy males and females stayed overnight in a room calorimeter on four 
separate occasions.  While in the calorimeter, they participated in meal and exercise 
challenges.  The subjects took part in one of two exercise sessions on the treadmill 
(high intensity – short duration or low intensity – long duration).  They were also 
provided one of two treatment beverages for lunch (high carbohydrate or high fat 
shake).  Blood samples were collected before and 30, 60, 90, and 120 minutes after 
breakfast and lunch to measure glucose, insulin, and non-esterified fatty acids 
(NEFAs). Metabolic flexibility was calculated in a manner similar to the literature, 
and new metabolic flexibility variables were also considered including the rate of 
change of RQ (slope) following exercise or a meal and the lag in RQ following 
exercise.  Delta RQ - calculated as the difference between a two hour average night 
RQ and a two hour average morning RQ - was negatively correlated to % body fat, 
positively correlated to VO2peak, and trending negatively with age.  The post-lunch 
slope of RQ was significantly larger following the high carbohydrate shake compared 




was negatively correlated with age and % body fat and positively correlated with 
VO2peak.  This study shows that the non-invasive room calorimetry method can be 
used to measure many metabolic flexibility variables.   
2.2 Introduction 
 
The phrase “metabolic flexibility” was termed by Kelley and Mandarino [21] 
and is specifically defined as “the capacity to switch from predominantly lipid 
oxidation and high rates of fatty acid uptake during fasting conditions to the 
suppression of lipid oxidation and increased glucose uptake, oxidation, and storage 
under insulin-stimulated conditions.”  Typically, MF is measured as the difference 
between insulin-stimulated respiratory quotient (RQ) and fasting RQ; however, not 
all studies that discuss MF calculate ∆RQ.  Some discuss MF in terms of adjusting fat 
oxidation [14, 15] or by the variance in insulin and RQ after a meal [16].  A 
hyperinsulinemic-euglycemic clamp and a hood calorimeter are commonly used to 
measure MF [7-11], but an indirect room calorimetry could be used as well.  Unlike 
the hyperinsulinemic-euglycemic clamp, room calorimetry alone is noninvasive and 
allows the subject to be ambulatory; therefore, they can perform tasks like walking on 
a treadmill or eating.  It also allows for a more physiological response, whereas in the 
clamp technique, insulin and glucose are infused via a catheter, and blood 
measurements would determine the amounts of glucose to infuse from outside the 
body.  There is “noise” associated with the calorimeter that does not allow for 
observing the instantaneous measures of RQ.  The RQ would be averaged over some 
time period, but that eliminates the effects of major deviations collected during the 




average, yet close examination of the data consistently reveals an increase in RQ 
during a meal or during exercise. 
A new method has been developed that smoothes the room calorimeter data so 
that it can be evaluated “instantaneously” (in 1-2 minute intervals) [29].  This means 
that variations in RQ, O2 consumption, and CO2 production can clearly be observed 
during and immediately after meals or exercise.  From this new insight into the data, 
it is now possible determine how quickly a subject switches fuel sources as the result 
of an event.  For example, during exercise, a subject’s RQ increases to reflect use of 
carbohydrates for energy, and it typically would increase almost simultaneously with 
VO2 (energy expenditure).  Alcohol trials have confirmed that this new method 
provides physiological data that is separate from any calorimeter noise (unpublished 
data).  This method would allow for the usage of a room calorimeter to measure 
variables of MF to determine how the results compare to those in the literature that 
use other methods.   
The primary objectives of this study were (1) to use room calorimetry to 
measure metabolic flexibility and to compare the results to those collected using other 
methodologies; (2) to examine the effects of diet composition and exercise 
interventions on metabolic flexibility variables (∆RQ, slope of RQ, variance of RQ); 
and (3) to see if there are any correlations that can be established between the 
metabolic flexibility variables and the physical characteristics of the subjects (age, 
BMI, % body fat, VO2peak, and HOMA-IR). It is hypothesized that metabolically 
inflexible subjects will have a slower rate of change (smaller slope) after a diet or 




subjects.      It is hypothesized that subjects with a higher VO2peak and lower body fat 
will switch substrate use faster (have a steeper RQ slope) than less aerobically fit 
subjects.  The high carbohydrate lunch shake will result in a larger RQ response and a 
quicker response than the high fat meal.  Following exercise, the new MF lag time 
variable will be longer for subjects with a higher % body fat and lower VO2peak.   In 
addition, subjects that are more fit (higher VO2peak, lower body fat) will have a 





Subjects were recruited from the area around the Beltsville Human Nutrition 
Research Center (BHNRC) and at the University of Maryland via fliers and emails.  
All procedures were approved by the MedStar Health Research Institute Institutional 
Review Board.  The University of Maryland Institutional Review Board (IRB) has an 
authorization agreement in place with the MedStar Health Research Institute IRB for 
this study.  Volunteers were required to attend an information meeting to learn about 
the study and ask any questions.  If they were interested in participating, they were 
asked to complete a study application and provide written informed consent before 
participating in any aspect of the study.  Volunteers were then required to complete a 
health history questionnaire and come to the Center for a health screening.  During 
this visit, their height, weight, and blood pressure were measured and body mass 
index (BMI) was calculated.  The volunteers also provided a blood and urine sample 




blood count (CBC), thyroid stimulating hormone (TSH), fasting glucose, and 
urinalysis.  When the lab results were received, a certified nurse practitioner reviewed 
the subjects’ charts to determine who was eligible to participate.  Of the eligible 
volunteers, 16 (8 men and 8 women) were selected to form a homogeneous group to 
take part in the study (Figure 2.1).  Volunteers were between the ages of 22 and 35, 
nonsmokers, and had no history of diabetes, cancer, metabolic disorders (Table 2.1).  
Subjects also required no special diets and did not have any food allergies.  Subjects 
were advised that participation was voluntary. 
 
Table 2.1: Ineligibility Criteria  
(as listed on page 2 of the Informed Consent) 
• Younger than 22 years old or older than 35 years old 
• Women who have given birth during the previous 12 months 
• Pregnant women or women who plan to become pregnant or become pregnant 
during the study 
• Lactating women 
• History of bariatric or certain other surgeries related to weight control 
• History or presence of  diabetes, kidney disease, liver disease, certain cancers, 
gout, hyperthyroidism, untreated or unstable hypothyroidism, gastrointestinal 
disease, pancreatic disease, other metabolic diseases, or malabsorption syndromes 
• Smokers or other tobacco users (within 6 months prior to the start of the study) 
• History of eating disorders or other dietary patterns which are not consistent with 
the dietary intervention (e.g., vegetarians, very low fat diets, high protein diets) 
• Volunteers who have lost 10% of body weight within the last 12 months or 
who plan to initiate a weight loss program during the next 10 months 
• Unable or unwilling to give informed consent or communicate with study staff 
• Self-report of alcohol or substance abuse within the past 12 months and/or 
current acute treatment or rehabilitation program for these problems (long-
term participation in Alcoholics Anonymous is not an exclusion) 
• Other medical, psychiatric, or behavioral factors that in the judgment of the 
Principal Investigator may interfere with study participation or the ability to 







29 (16 M, 13 F) 
volunteers attended an 
information meeting and 
consented to participating 
in the study 
27 (15 M, 12 F) 
volunteers screened 
4 Females excluded: 
1 ineligible, 3 not selected 
7 Males excluded: 
1 ineligible, 6 not selected 
8 Females randomly 
assigned to 1 of 8 treatment 
sequences 
(4 calorimeter stays/subject) 
 
8 Males randomly assigned 
to 1 of 8 treatment 
sequences 
(4 calorimeter stays/subject) 
1 Female dropped after 
completing 3 calorimeter 
stays 
(no DXA scan performed) 
 
 
0 Males dropped 
63 out of 64 calorimeter 
runs completed 






The study involved volunteers staying overnight in a room calorimeter on four 
separate occasions with at least two weeks between each session.  At each stay, they 
would receive one of four treatment combinations involving exercise (high or low 
intensity) and diet (a high fat or high carbohydrate shake for lunch).  The treatment 
sequence was developed using two 4x4 Latin Squares for each gender.  Subjects were 
then randomly assigned to a treatment sequence.  One male and one female 
completed each of the 8 sequences.  Subjects were compensated $150 for each 
calorimeter stay, and payment was received at the completion of the study.   
2.3.3 Diet 
 
On day one of the calorimeter stay, subjects were provided a base diet 
(approximately 58% carbohydrates, 25% fat, and 17% protein).  Their kcal level was 
determined by estimating total energy expenditure with prediction equations (Harris-
Benedict and Miflin-St. Joer).  Kilocalorie levels were in increments of 200 kcal.  The 
subjects came to the Center in the morning to consume breakfast and receive a packed 
lunch to take with them.  Subjects were limited to 16oz of caffeinated beverages 
(coffee, tea, diet soda) at breakfast on Day 1 and were required to consume the same 
thing every morning that they came to the Center for breakfast.  When they returned 
in the late afternoon, they consumed dinner in the calorimeter at approximately 6 PM.  
They had to finish dinner by 6:45PM to ensure that they were fasted for 12 hours 
before their baseline blood draw the following morning.  The times of their first and 




received a standard breakfast of waffles and syrup, which contained 91g of 
carbohydrates (Table 2.2) to simulate an oral glucose tolerance test (OGTT).  They 
had 15 minutes to consume breakfast, and first and last bite times were recorded.  
They also received a standard lunch at approximately 12 PM which consisted of 
either a high fat (HF) or high carbohydrate (HC) shake.  Table 2.2 provides the 
composition of the shakes.  The shake recipes were modified from shakes used in a 
previous study at the Center [94].  The HF shake was made with heavy cream, 
powdered egg whites, water, sugar, aspartame, and cocoa powder.  The HC shake was 
composed of plain rice milk, non-fat vanilla coffee creamer, powdered skim milk, 
water, sugar, and cocoa powder.  They were required to consume the shakes in 15 
minutes, and first and last bite times were recorded.  Subjects had to consume all food 
that was provided to them on the treatment days, and they could drink as much water 
as they wanted.  When subjects were not taking part in a calorimeter stay, they could 
consume their typical diet at home.   
Table 2.2: Day 2 Standardized Menu 
Waffles & syrup was served for breakfast and either the HC or HF shake was served for lunch 
 Energy (kcal) Carbohydrate 
(g) 
Fat (g) Protein (g) 
Waffles & 
Syrup 486 91 11 8 
High CHO 
Shake 548 123 3 7 
High Fat 







Prior to the calorimeter stays, subjects reported to the Center to perform a 
VO2peak test.  When they arrived, their blood pressure was measured.   The VO2peak 
procedures were explained to them, and they were advised not to change their 
physical activity regimen during the duration of the study.  Subjects were fitted with a 
facemask and wore a heart rate monitor (Polar Wearlink® 31, Polar Electro Inc., 
Lake Success, NY) during the test.  A metabolic cart (TrueOne® 2400, Parvo Medics, 
Inc., Sandy, UT) was used to determine the oxygen consumption of the air flowing 
through the facemask.  The metabolic cart was calibrated each time it was powered 
on.  The VO2peak test was performed on a treadmill (Trackmaster TMX425C, Full 
Vision, Newton, KS) using the Bruce protocol (Table 2.3), which involved the speed 
and incline of the treadmill increasing every 3 minutes.  The test ended when the 
subject decided that he or she could no longer continue.  Each subject would then 
perform a cool down.  Thirty second averaging was done on the subjects’ breaths.  
The VO2peak results were used to calculate the treadmill settings for the exercise 
session in the calorimeter.  An RQ of at least 1.1 and a comparison of their heart rate 
(HR) during the test to their age predicted maximum HR were used to determine if 
the test was successful.  Evaluation of the graphs to determine if a subject’s VO2 and 
RQ plateaued or a rate of perceived exertion (RPE) of at least 8 (on a scale of 1 to 10) 
were also considered for determination of a successful test.  Subjects were provided a 






Table 2.3: Bruce Protocol 
Stage Minutes Speed (mph) % Grade 
1 0-3 1.7 10 
2 3-6 2.5 12 
3 6-9 3.4 14 
4 9-12 4.2 16 
5 12-15 5.0 18 
6 15-18 5.5 20 
7 18-21 6.0 22 
During the VO2peak testing, subjects start at stage 1 with the treadmill set at 
a speed of 1.7 mph and an incline of 10%.  Every 3 minutes the speed and 
incline of the treadmill change.  Subjects proceed through the stages until 
they can no longer continue. 
 
 
The two exercise treatments performed on the treadmill (Smooth Fitness 
7.1HR, Smooth Fitness, Mt. Laurel, NJ) in the calorimeter were high intensity – short 
duration (HI) and low intensity – long duration (LI).  HI was performed at 
approximately 85% of the subjects’ VO2peak and involved four five-minute sessions 
on the treadmill with 5 minutes of rest in between.  LI was one 40 minute session on 
the treadmill at approximately 65% of the subjects’ VO2peak.  A standard metabolic 
equation was used to calculate the appropriate speed for each subject at an incline of 
2 (VO2 = (S·0.1) + (S·G·1.8) + 3.5 where S=speed (m/min) and G=grade in 




treadmill when they were told to do so and to not perform any other exercises.  Staff 
monitored the exercise sessions to record the start and stop times of the sessions and 
to ensure that the subjects were not struggling or having difficulty using the treadmill.  
Exercise occurred at approximately 10AM, about 30 minutes after the final morning 
blood draw.  Subjects did not consume water during the exercise period to prevent 
any temperature fluctuations in the core temperature pill (see Ambulatory Monitoring 
Device section below).   
2.3.5 Calorimeter 
 
Subjects stayed overnight in an indirect room calorimeter to determine energy 
expenditure.  They stayed in the same calorimeter on each occasion to prevent any 
calorimeter variations.  The calorimeter measures the oxygen consumed and the 
carbon dioxide produced.  Smoothing the calorimeter data by a method discussed 
previously [29] also allows for evaluation of “instantaneous” changes in the volume 
of oxygen consumed (VO2) and respiratory quotient (RQ).  All urine was collected 
during the calorimeter stay to determine urinary nitrogen for estimation of protein 
oxidation.  VO2, VCO2, and urinary nitrogen values were used in the equations by 
Livesey et al. to calculate carbohydrate, fat, and protein oxidation.  Subjects entered 
the calorimeter at approximately 4:45 PM and remained in the calorimeter for 23.5 
hours.  The calorimeters are approximately 9’ by 12’ and contain a Murphy bed, desk, 
TV, DVD player, computer, phone, treadmill, air conditioner, toilet, and sink.  Meals 
were served through an airlock in the door.  On the subjects’ first stay, they were 
given a “tour” of the calorimeter where they received instructions on how to use the 




explained.  The calorimeter lab was staffed throughout the entire calorimeter stay, and 
the calorimeter doors were not locked in case of an emergency.  Subjects were asked 
to leave at least one window blind open except for when they needed privacy 
(changing, using the bathroom) so that staff could check on them.  Subjects were 
allowed to do low-activity tasks such as lying down, watching TV, reading, and 
computer/desk work when they did not have any study requirements.  The time the 
subject entered the calorimeter (when the door closed) and exited (when the door was 
opened) was recorded.  Prior to the subjects entering the calorimeter, alcohol lamps 
were burned in order to increase the CO2 levels in the calorimeter.  This allowed the 
calorimeter to acclimate more quickly upon the subjects’ entrance.  Energy 
expenditure, substrate oxidation, ∆RQ, post lunch RQ AUC, RQ variance, post meal 
RQ slopes, and exercise RQ slopes were calculated.   Lag between RQ and VO2 
following exercise was calculated using cross-correlation.   
2.3.6 Blood Draws 
 
On the morning of Day 2, subjects had an IV catheter placed in the antecubital 
area of the arm by a nurse or phlebotomist.   The subjects inserted one arm through an 
arm port located in one of the calorimeter windows for blood draws and BG 
measurements.  Two fasting baseline blood draws were performed prior to breakfast.  
Blood was then drawn 30, 60, 90, and 120 minutes after the subjects finished 
breakfast.  Blood was then drawn immediately prior to lunch and then 30, 60, 90, and 
120 minutes after the subjects finished the lunch shake.  10mL of blood was drawn at 
each time point for a total of 110mL during each calorimeter stay – approximately ½ 




draws were recorded.  For each time point, serum, plasma EDTA, and plasma NaF 
vacutainers were collected and inverted.  The EDTA and NaF vacutainers were 
placed on ice until they were centrifuged.  The serum tube sat for 30-60 minutes at 
room temperature to allow for clotting and was centrifuged at room temperature.  
After centrifugation, the serum and plasma vacutainers were aliquoted into the 
appropriate labeled cryovials and stored in a -80oC freezer for analysis at a later time.    
Serum insulin was measured by enzyme-linked immunosorbent assay 
(ELISA, EMD Millipore Corporation, Billerica, MA) on a DSX® workstation 
(Dynex Technologies, Chantilly, VA).  Plasma glucose was measured by performing 
a colorimetric test using a Vitros GLU slide on a clinical chemistry analyzer (Vitros, 
Ortho Clinical Diagnostics, Rochester, NY).  Serum NEFAs were measured by an 
enzymatic colorimetric assay (Wako Diagnostics, Richmond, VA) on a clinical 
chemistry analyzer (Vitros, Ortho Clinical Diagnostics, Rochester, NY).  All blood 
samples were run in duplicate.  Homeostatic model assessment – insulin resistance 
(HOMA-IR) was calculated as described previously [96].  The 2 hour post breakfast 
and lunch AUC was analyzed for glucose, insulin, and NEFA.  The variance of 
insulin was calculated for approximately 2 hours post breakfast and lunch. 
2.3.7 Urine Collection 
 
Urine was collected during the entire calorimeter stay in order to analyze 
urinary nitrogen.  Subjects were provided with a 4L urine jug in the calorimeter.  Ten 
grams of boric acid was placed in the urine jug prior to collection to function as a 
preservative.  The tare weight of the jug and boric acid was recorded.  A second 




was weighed, and the weight was recorded.  The urine jug was shaken, and the urine 
was aliquoted into two 5 mL cryovials and one 15 mL centrifuge tube.  The samples 
were stored in a -20oC freezer until they were analyzed.  If two jugs were used, 5% of 
each sample was mixed together and then aliquoted.  A nitrogen analyzer (TruMac, 
LECO Corporation, St. Joseph, MI) was used to measure urinary nitrogen, and 
samples were run in duplicate. 
2.3.8 Body Fat Composition 
 
On the subjects’ third or fourth calorimeter stay, a dual-energy X-ray 
absorptiometry (DXA) scan was performed to determine their percent body fat 
(Hologic QDR Discovery A, Hologic, Bedford, MA).  A quality control test was 
performed when the DXA was turned on for the day.  The scan was performed when 
the subjects exited the calorimeter on Day 2.  Staff would go through prescreen 
questions with the subject to verify that there were no safety exclusions (such as 
having an X-ray with contrast in the last week) and that they were not wearing any 
metal.  The subjects would then be positioned in the center of the table and informed 
to lie still and close their eyes.   The whole body scan took approximately 4 minutes.  
After the scan, the staff would perform the analysis of the scan by segmenting the 
body and running the program.  Subjects were provided a copy of their results upon 
completion of the study.  Because this scan involved X-rays, female subjects provided 
a separate urine sample on the day of the DXA scan so that a pregnancy test could be 
performed.  This sample was kept in the refrigerator and added to the urine collection 
jug prior to processing.  A positive test result would exclude the subject from being 






On Day 1, subjects reported to the Center for breakfast between 6:30 and 8 
AM.  When they arrived, they were weighed.  They then had the sensor portion of the 
CGMS inserted.  While the sensor was “wetting”, they consumed breakfast and 
received a packed out lunch.  Diet technicians monitored their breakfast consumption 
and recorded their caffeinated beverage intake (type and amount).  When they 
finished eating, the transmitter portion of the CGMS was connected to the sensor and 
they could leave the facility.  Subjects returned to the Center at approximately 4:30 
PM.  They were fitted with the ambulatory monitoring device and swallowed the 
temperature transmitting pill.  Their blood glucose was measured, and then they 
entered the calorimeter.  Figure 2.2 shows the approximate timeline of the activities 
that occurred while the subject was in the calorimeter. During each session, the 
subjects would participate in one of four exercise/meal treatment combinations: 
• A: low intensity – long duration / high fat shake 
• B: high intensity – short duration / high fat shake 
• C: low intensity – long duration / high carbohydrate shake 







2.3.10 Statistical Analysis 
 
The sample size was selected based on a previous calorimeter study that 
involved detecting differences in fat oxidation.  SAS 9.4 (SAS Institute, Cary, NC) 
was used to analyze the data using a mixed model.  Meal treatments, exercise 
treatments, and sequence of treatments were the fixed effects and subject nested 
within sequence was the random effect.    Least-square means were also evaluated.  
When sequence was not significant, it was removed from the model statement and the 
analysis was repeated.  Pearson’s correlation coefficients were calculated to evaluate 
the correlations between metabolic flexibility variables (∆RQ, slope of RQ, AUC of 
RQ, and variance of RQ and insulin) and the physical characteristics of the subjects 
(age, BMI, % body fat, VO2peak, and HOMA-IR).  Tests were significant at α = 0.05.  
Results are reported as least-square means ± standard error of the mean (LSM ± 
































6 AM 7:00 8:00 9:00 10:00 11:00 12:00 1:00 2:00 3:00 4:00 5:00 
 
Figure 2.2: Schedule for Day 1 and Day 2 of the calorimeter session.   





Eight men and 7 women completed the study.  One woman dropped out of the 
study after completing 3 out of 4 treatments and did not complete a DXA scan. Her 
results for the treatments that she did complete were included in the analysis.  Table 
2.4 provides a summary of the physical characteristics of the selected subjects.     
 
 
2.4.1 Energy Expenditure and Substrate Oxidation 
 
Average RQ during the calorimeter run was significantly different between 
the meal treatments (HC: 0.86 ± 0.01 vs. HF: 0.84 ± 0.01; p < 0.0001) but not the 
exercise treatments.  The average RQ was calculated between the times of 7:11 PM 
on Day 1 and 3:18 PM on Day 2, since this data range was available for all 63 
calorimeter runs.  The average RQ was negatively correlated with VO2peak (r = -
 Males Females Range 
Age (years) 29 ± 2 25 ± 1^ 22 - 34 
BMI (kg/m2) 25.3 ± 1.6 24.1 ± 1.2 19.3 – 31.0 
VO2max (ml/kg/min) 43.7 ± 4.8 38.9 ± 2.1 29.3 – 63.6 
% Body fat* 19.5 ± 2.8 28.2 ± 2.4^ 9.2 – 37.6 
Fasting glucose 
(mg/dl) 90 ± 2 84 ± 3 71 – 99 
Blood pressure 
(mmHg) 
119 ± 5/ 
70 ± 3 
121 ± 7/ 
70 ± 3 
100 – 157 /  
58 - 83 
HOMA-IR 1.53 ± 0.43 1.70 ± 0.39 0.47 – 4.49 
 
Means ± SEM 
*One female subject dropped before completing a DXA scan. 
^significantly different (p<0.05) 




0.34; p=0.0066).  Energy expenditure during this same time period was also 
significantly different between meal treatments (HC: 1908 ± 81kcal vs. HF: 1850 ± 
80 kcal; p = 0.0035) and not significantly different between the exercise treatments.  
The energy expenditure was positively correlated with BMI (r = 0.36; p = 0.0040) 
and VO2peak (r = 0.52; p < 0.0001) and negatively correlated with % body fat (r = -
0.30; p = 0.0192).  Substrate oxidation (in grams) was calculated over this time 
period, and all macronutrients had significantly different oxidation amounts between 
the meal treatments (Figure 2.3).  Exercise treatments and the exercise*meal 
interaction were not significant.   
  
Figure 2.3: Macronutrient oxidation  
The total amount of carbohydrate, fat, and protein gram oxidized during 








2.4.2 Metabolic Flexibility in Response to Meals 
 
The first variable considered was the slope of RQ following the meals in order 
to determine the rate of change, how quickly the RQ changes in response to the 
meals.  The slope of RQ following dinner and breakfast was not affected by the 
treatments, since the treatments were not administered until after the completion of 
breakfast on Day 2.  There were no significant correlations between the dinner and 
breakfast slopes and the subjects’ physical characteristics (BMI, % body fat, age, 
VO2peak, or HOMA-IR).  However, there was a significant meal effect on the lunch 
slope where the high carbohydrate beverage had a larger slope than the high fat 
beverage (0.0049 ± 0.0004 vs. 0.0033 ± 0.0004; p = 0.0059) (Figure 2.4).  This 
means that the RQ increased at a faster rate for the high carbohydrate shake.  The post 
lunch area under the curve (AUC) of the RQ (calculated for approximately 185 
minutes after lunch with the baseline value being 0.7 instead of 0) was also larger for 
the high carbohydrate beverage than the high fat beverage (0.024 ± 0.001 vs. 0.010 ± 
0.001; p < 0.0001).  The post lunch RQ AUC was negatively correlated with 
VO2peak (r = -0.25; p = 0.0465).   
Figure 2.4: Lunch slope 
Slope of RQ following the treatment lunch. P = 0.0059; HC – high 





 ∆RQ was calculated in a method (Method A) that was similar to what has 
previously been performed in the literature using the clamp method [7-11].  The RQ 
data for the 30 minutes prior to breakfast was averaged and considered the fasting 
RQ.  Two hours after breakfast was consumed, another 30 minute average RQ was 
calculated as the insulin-stimulated RQ.  The difference was calculated as the ∆RQ.  
There were no significant correlations between ∆RQ and the subjects’ physical 
characteristics.  Sorting ∆RQ by gender resulted in females having a positive 
correlation between ∆RQ and VO2peak (r = 0.51; p = 0.0032).  Fasting RQ was 
negatively correlated with VO2peak (r = -0.32; p = 0.0107).   
A second method to calculate ∆RQ was also utilized (Method B).  For this 
method, RQ between 7AM and 9AM was averaged as the insulin stimulated RQ 
(breakfast was served during this time) and fasting RQ was the average RQ between 
2AM and 4AM.  For method B, ∆RQ was negatively correlated with % body fat (r = -
0.30; p=0.0202), positively correlated with VO2peak (r = 0.43; p=0.0004), and 
trending negatively with age (r = -0.25; p=0.0502) (Figure 2.5).  
The change in RQ following lunch was also considered with the pre-lunch RQ 
being the 30 min average RQ immediately prior to lunch and the post lunch RQ being 
the 30 minute average RQ 2 hours after lunch.  In this case, there was a meal 
treatment effect on the post lunch RQ and the ∆RQ with the high carbohydrate shake 
resulting in a larger change in RQ (0.16 ± 0.01 vs. 0.02 ± 0.01; p < 0.0001).  There 
were no significant correlations between ∆RQ and the subjects’ physical 
characteristics even when sorting by exercise treatment or gender.  The pre-lunch RQ 





Figure 2.5: ∆RQ correlations 
∆RQ as calculated by the method A is (a) negatively correlated with % Body Fat (p=0.0202), (b) 








RQ following the low intensity session (0.76 ± 0.01 vs. 0.74 ± 0.01; p = 0.0130).  
This pre-lunch RQ was negatively correlated with VO2peak (r = -0.26; p=0.0363).  
Also the fasting RQ was significantly higher than the pre-lunch RQ for both exercise 
treatments, demonstrating that the exercise sessions had an impact in decreasing the 
pre-lunch RQ (Figure 2.6). 
 
When examining the variance of RQ and insulin after lunch, it was found that 
the meal treatment had a significant effect on the variance of insulin with the high 
carbohydrate shake having a significantly higher variance than the high fat shake 
(p<0.0001).  Relevant correlations involving the variance in RQ and insulin can be 
found in Table 2.5.   
 
Figure 2.6: Pre-meal RQ 
The 30 minute average RQ before breakfast and lunch are compared between the 
exercise treatments.  * Breakfast pre-meal RQ is significantly different than lunch 
for both groups (p < 0.001).  #  Lunch pre-meal RQ is significantly different 
between treatments (p = 0.0130).  HI – high intensity, LI – low intensity 
* 
*















2.4.3 Metabolic Flexibility during Exercise 
 
For the exercise portion of the protocol, the average RQ during the session 
was significantly higher for the high-intensity treatment than the low intensity 
treatment (0.96 ± 0.01 vs. 0.93 ± 0.01; p < 0.0001).  The average RQ was also 
negatively correlated with % body fat (r = -0.26; p=0.0424).  There were no 
significant differences in the energy expenditure between the treatments.  The energy 
expenditure was negatively correlated with age (r = -0.39; p=0.0017) and % body fat 
(r = -0.64; p<0.0001) and positively correlated with VO2peak (r = 0.86; p<0.001).  
The slope of RQ at the start of the exercise session was also evaluated.  The exercise 
treatment had no effect on the slope, but it was positively correlated with VO2peak (r 
= 0.67; p<0.0001).  The slope was also negatively correlated with age (r = -0.31; 
p=0.0138) and % body fat (r = -0.55; p<0.0001) (Figure 2.7).   
Table 2.5: RQ and insulin variances 
Correlation coefficients for the physical characteristics of the subjects vs. the 
RQ and insulin variances 
* significant correlation (p<0.05) 
RQ and insulin variances for 2 hours post-meal were calculated following both breakfast 
and lunch.  For instances of missing data, the calculation was only performed if the data 
included baseline and 120 min blood samples. 
 Breakfast Lunch 
Physical 
Characteristics RQ variance 
Insulin 
variance RQ variance 
Insulin 
variance 
Age -0.079 0.26* -0.029 0.15 
BMI -0.25* 0.49* -0.18 0.24 
% Body Fat 0.024 0.35* 0.009 0.29* 
VO2max -0.093 -0.31* -0.12 -0.21 






Figure 2.7: Exercise RQ slopes 
The slope of RQ during exercise is negatively correlated with (a) age 
(r=-0.31, p=0.0138) and (b) % body fat (r=-0.55, p<0.0001) and 








Lag was calculated for the exercise session since excess CO2 is expired by the 
subjects at the completion of the session.  There were no exercise treatment effects on 
the lag; however, it was negatively correlated with VO2peak (r=-0.30, p=0.0161) 
(Figure 2.8).   
The MF during exercise was also calculated in a manner similar to Prior et 
al.[13].  For this calculation, the pre-exercise RQ was determined by averaging the 
RQ for the 10 minutes prior to the start of the exercise session.  The exercise RQ was 
the average RQ during the final 10 minutes of the session.  MF (∆RQ) was then 
calculated.  MF of exercise was significantly different between the exercise 
treatments (HI: 0.056 ± 0.012 vs. LI: 0.088 ± 0.012; p = 0.0445).  However, the 
exercise RQ and pre-exercise RQ was significantly higher for the HI exercise.  MF of 
exercise was positively correlated with HOMA-IR (r = 0.26; p = 0.0430); however, 
when examining the HOMA-IR and each exercise treatment separately, the 
correlation was not significant.    
Figure 2.8: Post exercise lag time 
The lag in RQ following exercise is negatively correlated with VO2max 




2.4.4 Glucose, Insulin, and NEFAs  
 
AUC was calculated for glucose, insulin and NEFAs following the standard 
breakfast and the treatment lunch.  For instances of missing data, the calculation was 
only performed if the data included baseline and 120 min blood samples.  The 
exercise and meal treatments were not administered before breakfast; therefore, only 
correlations with various physical characteristics were examined.  These correlations 
can be found on Table 2.6.  Glucose AUC for 2 hours following lunch was 
significantly different between the high carbohydrate beverage and the high fat 
beverage (HC: 15,172 ± 405 mg/dL vs. HF: 10,156 ± 399 mg/dL; p<0.0001).  Insulin 
AUC for 2 hours after lunch was also significantly different between the meal 
treatments (HC: 5331 ± 400 µU/mL vs. HF: 945 ± 396 µU/mL; p<0.0001) with the 
exercise treatment only having a trending effect (p=0.0859).  There was a significant 
meal*exercise treatment interaction for the NEFA AUC at lunch (p=0.0482).  Figure 
2.9 provides a graph of the significant differences of NEFA AUC for the four 
treatment combinations.  Table 2.6 provides the significant correlations between the 












Figure 2.9: NEFA area under the curve 
Non-esterified fatty acids AUC for 2 hours following lunch for each 
treatment.  Treatments with different letter are significantly different (p 
< 0.05).  
Table 2.6: Glucose, insulin, and NEFA area under the curve 
Correlation coefficients for the physical characteristics of the subjects and the AUC 
following breakfast and lunch for glucose, insulin, and non-esterified fatty acids 
(NEFA) 
* statistically significant (p<0.05) 
 Breakfast Lunch 
Physical 
Characteristics Glucose Insulin NEFA Glucose Insulin NEFA 
Age 0.59* 0.38* 0.41* 0.11 0.19 -0.034 
BMI 0.52* 0.63* 0.52* 0.17 0.29* 0.10 
% Body Fat 0.33* 0.46* 0.16 0.33* 0.35* 0.20 
VO2max -0.45* -0.41* -0.28* -0.20 -0.28* -0.12 







The main objectives of this study were to (1) to use room calorimetry to 
measure metabolic flexibility and to compare the results to those collected using other 
methodologies; (2) to examine the effects of diet composition and exercise 
interventions on metabolic flexibility variables (∆RQ, slope of RQ, variance of RQ); 
and (3) to see if there are any correlations that can be established between the 
metabolic flexibility variables and the physical characteristics of the subjects (age, 
BMI, % body fat, VO2peak, and HOMA-IR). Some of the metabolic flexibility 
variables that we considered were new variables that have not been examined 
previously (to the best of our knowledge).  We also used our data to perform the MF 
calculations that have been done previously in literature for comparison purposes.   
 The closest representation to the methods that we used was the study by 
Russell et al. [60] because they did not use the clamp method and used a hood 
calorimeter alone to evaluate MF.  For their study, the subjects were passively 
stretched while under the hood calorimeter.  The subjects then came out from under 
the hood to consume a glucose load and returned to the hood when they finished.  
They found that the control subjects were more metabolically flexible than the 
subjects with T2D or the subjects with a family history of T2D (there was no 
difference in MF between subjects with T2D and the subjects with a family history of 
T2D).  The benefit of room calorimeter method as opposed to the hood calorimeter 
alone is that it allows for continuous monitoring while eating, so that the subjects do 




allows the subject more mobility so that they can perform different exercises like 
running on the treadmill or using resistance bands.  
When we calculated ∆RQ in a similar manner to studies that used the  
hyperinsulinemic-euglycemic clamp (method A), we didn’t observe any correlations 
between MF and the physical characteristics of the subjects.  However, MF, as 
evaluated by calculating ∆RQ via method B, was negatively correlated with % body 
fat and positively correlated with VO2peak which was the same results found 
previously for a group of young men [8, 46].  We also observed a negative trend with 
age as seen previously in a group of men and women [11].   
The ∆RQ in response to the lunch was calculated and there was a larger 
difference between the pre-lunch RQ and post-lunch RQ when the subjects consumed 
the high carbohydrate shake.  This was not surprising, because RQ is 1 when a person 
is only oxidizing carbohydrates and 0.71 when a person is only using fat.  The pre-
lunch RQ was affected by the exercise that was done prior to the lunch, and it was 
negatively correlated to VO2peak.  This could mean that subjects with a higher 
VO2peak were better able to return their RQ to a baseline level following the exercise 
session.  It might be worth examining the results when providing the test meal as 
breakfast in order to eliminate any confounding factors like the exercise effect.   
 We also examined MF by the variance in RQ and insulin as was done by 
Bergouignan et al.[16].  They classified subjects as metabolically flexible if they had 
a large variance in RQ but a small variance in insulin.  As would be expected, the 
lunch beverage had an effect on the variance of insulin.  The only significant 




variance in insulin, meaning that subjects with more body fat had a difficult time 
keeping their insulin stable.  When examining the RQ variance after breakfast, it was 
found that subjects with a larger BMI or a larger HOMA-IR value had a lower 
variance in RQ.  This would mean that they were not experiencing a drastic increase 
in RQ in response to a high carbohydrate breakfast.  A person that is metabolically 
flexible would be expected to have a larger and possibly quicker increase in RQ 
following a meal.  In terms of insulin, subjects that were older, had a high BMI or % 
body fat, had a larger HOMA-IR value, or had a lower VO2peak had a higher 
variance in insulin following breakfast.  Their insulin control was not as good 
following the breakfast and one would expect it to be more stable if they were 
metabolically flexible.  Taken with what we have seen in literature regarding the 
characteristics of a metabolically flexible person, these results would not be 
surprising. 
 Another method we explored was metabolic flexibility during exercise.  The 
change in RQ during the exercise was significantly different between the exercise 
treatments.  Prior et al. [13] calculated the change in RQ only for submaximal 
exercise (50 and 60% of VO2max) and found that the obese subjects with impaired 
glucose tolerance had lower MF compared to those with normal glucose tolerance.  
They also reported that there was no correlation between MF during the clamp and 
MF during exercise.  Looking at the LI exercise treatment alone for the current study, 
there were no significant correlations between the physical characteristics of the 




and nondiabetic, and we did not assess their glucose tolerance levels.  It would be 
interesting to evaluate this with an older population and diabetics.  
 The slope of the RQ in response to meals of varying diet composition was one 
of the new MF variables we examined.  We did not observe any correlations between 
the physical characteristics of the subjects and the slope of RQ following dinner 
(mixed macronutrient meal) or breakfast (high carbohydrate).  The slope of RQ 
following lunch was larger for the high carbohydrate shake than the high fat meaning 
that there was a faster rate of change in the RQ after the high carbohydrate beverage.  
This isn’t surprising due to the carbohydrate providing a large insulin response and 
the RQ of using carbohydrates alone would be 1.  There were no significant 
correlations between the lunch slope and the subjects’ physical characteristics, and 
this was also the case when the correlations were sorted by meal type.  It would be 
interesting to perform this analysis on a wider subject population (larger age range, 
Type 2 diabetics) to see if there would be a change in the rate or any correlations.  I 
would hypothesize that type 2 diabetics would have a slower rate of change in RQ 
(smaller slope) than lean, non-diabetics.   
 Another MF variable considered was the AUC of RQ following the diet 
treatment lunch.  The AUC of RQ was larger for the high carbohydrate shake than the 
high fat shake.  This would be reflective of the fact that the high carbohydrate shake 
would cause a large rise in RQ.  The negative correlation between post lunch RQ 
AUC and VO2peak suggests that fitter subjects were better able to return to a baseline 
level following their response to lunch.   




When considering MF in relation to the exercise treatments, the slopes of RQ 
at the start of exercise were associated with fitness level.  The slope was positively 
correlated with VO2peak and negatively correlated with age and % body fat.  This 
demonstrates that subjects with a better aerobic capacity and less body fat adapted 
their RQ more quickly to the exercise.  Again, it also shows that the older subjects 
adapt more slowly to the exercise.   
Also, when analyzing the response in RQ to various exercise challenges, we 
determined that the new MF lag variable may be indicative of a subjects’ fitness level 
and not their metabolic flexibility.  The lag in RQ was caused by the excess CO2 
produced at the completion of the exercise session [97].  Lag was not affected by the 
type of exercise (low intensity vs. high intensity), but was negatively correlated with 
VO2peak.  The more physically fit a subject was, the shorter the lag in RQ following 
exercise.  A prior study performed at this facility found that the lag after exercise was 
positively correlated with age, reflecting that as a person gets older, it takes longer for 
them to rid their bodies of the excess CO2 [31].  This would make sense due to fitness 
levels declining as people age.        
     
  
Area under the curve for glucose, insulin, and NEFA for 2 hours after 
breakfast also reflect the differences associated with fitness level and body fat.  Older 
subjects had a larger AUC for glucose, insulin, and NEFAs.  BMI and HOMA-IR 
were positively correlated with AUC for glucose, insulin, and NEFAs.  VO2peak was 




positively correlated with insulin.  Subjects who were older, less fit, and with more 
body fat experienced larger and/or prolonged glucose, insulin, and NEFA responses 
to the meal. 
One limitation of this study is the small range of age.  The subjects were well 
distributed within our age range; however, it only spanned 14 years. Based on 
previous examinations, it would be worthwhile to perform these calculations on an 
older population as well to see if the correlations remain true.  The smaller sample 
size may have also limited our ability to see significant correlations.  More subjects of 
both genders would have allowed us to better explore gender differences as well.  
Also, unlike many of the metabolic flexibility studies in the literature, we did not 
have any subjects that were type 2 diabetic since it was an exclusion criteria for this 
study.   
In summary, we were able to measure MF variables without the use of the 
hyperinsulinemic-euglycemic clamp and observed the expected results.  The room 
calorimeter allowed us to continuously monitor the subject RQs during the meals and 















Chapter 3: Conclusions and Future Work 
 
In conclusion, we were able to measure metabolic flexibility variables using a 
room calorimeter and the appropriate data smoothing methods that reduce equipment 
noise.  The significance is that we had results that were similar to the literature 
without using a hyperinsulinemic-euglycemic clamp.  This is beneficial since the 
clamp method is invasive and does not give a true physiological response because the 
glucose levels are being controlled.  In addition, the clamp would not allow for eating 
meals or exercising during the procedure.  Using the  room calorimeter and 
smoothing the data allows the subjects to consume actual meals and be ambulatory to 
exercise so that RQ response can be monitored continuously.  The ability to examine 
small time intervals allows for the calculation of the actual rate of change in the RQ 
(slope) in response to a diet or exercise challenge.  The slope of RQ was affected by 
the diet composition of the lunch shake, but there were no significantly correlations 
with the subjects’ physical characteristics.  The slope of the rise in RQ in response to 
exercise was not affected by the type of exercise session, but subjects that were more 
aerobically fit (higher VO2peak) and had less body fat had a faster increase in RQ 
(larger slope of RQ).  Multiple methods of calculating MF demonstrated that subjects 
that were more fit and had less body fat were more metabolically flexible.     
This was the first calorimeter study performed at our lab where detailed data 
was collected to allow for analysis of these metabolic flexibility variables.  Previous 
calorimeter studies did not have the exact meal and exercise data or start and end data 




accuracy using the smoothing method.  We were also able to expand our data on 
younger subjects (under 35 years old).   
Future work should involve running a similar protocol with older subjects to 
see if the correlations that were seen with the younger population are true for the 
older population as well.  It would be beneficial to expand on the study of the 
exercise and meal slopes.  For this study, having diabetes was an exclusion factor, but 
many studies focus on the difference between subjects with and without T2D.  For 
comparison, it would be interesting to include a group of Type 2 diabetics when 
calculating these metabolic flexibility variables or take into account any family 
history of the disease.  We have recently completed a pacing study in the calorimeter 
that involved a protocol that was very similar to the metabolic flexibility study.  The 
main difference was the exercise session.  The meals were the same, so we could 
calculate slopes of meals and other MF variables to compliment and expand on the 




Appendix A: Summary of Select Metabolic Flexibility Articles 
 
Author Subjects Objective Results 
Kelley, Mandarino (2000)  
[21] 
N/A – Review article  • Coined the term “metabolic flexibility.” 
• Fasting – predominantly lipid oxidation; high 
rates of FA uptake. 
• Insulin-stimulated – suppression of lipid 
oxidation; increased glucose uptake, oxidation, 
and storage.   
Ukropcova et al. (2005) 
[46] 
16 young, healthy men with a 
range of BMIs, insulin 
sensitivities, and fat mass.   
To evaluate whether “the capacity 
of myotubes to oxidize fat in vitro 
reflects the donor’s metabolic 
characteristics.” 
• MF inversely correlated with body fat and free 
fatty acid (FFA) levels 
• MF positively correlated with IS, VO2max, and 
mitochondrial DNA. 
• Metabolic switching reflects the metabolic 
characteristics of the donor. 
• “Metabolic switching is an intrinsic property of 
skeletal muscle.”  
• Suppressability negatively correlated with MF 
and IS and positively correlated with body fat and 
fasting FFA levels. 
• Adaptability positively correlated with MF, IS, 
and aerobic capacity and negatively correlated 
with % body fat and fasting insulin levels. 




To establish if African-American 
women are metabolically inflexible. 
• Caucasian women had significantly higher fat 
oxidation during a high fat diet and higher 
carbohydrate oxidation during the low fat diet, 
whereas African American women had no 
significant differences.  




Ukropcova et al. (2007) 
[8] 
Young, sedentary men (16 
with a family history of 
diabetes and 34 without). 
To determine if “defects in substrate 
switching in response to insulin and 
a HFD (high-fat diet) are linked to 
reduced mitochondrial biogenesis 
and occur before the development 
of diabetes.” 
• Sleep RQ (maximal fat oxidation) during the 
HFD was negatively correlated to MF. 
• Mitochondrial DNA content was positively 
correlated to MF.   
• Subjects with a family history of diabetes had a 
higher sleep RQ (lower maximal fat oxidation 
during HFD), a decrease in mtDNA content, and 
a trend towards reduced MF (p=0.07). 
• No differences in the amount of body fat and 
visceral fat.   
Gaster (2007) 
[45] 
Myotubes from lean, obese, 
and type 2 diabetic subjects. 
To determine if “metabolic 
inflexibility is an intrinsic defect in 
myotubes established from obese 
and T2D subjects.” 
• Myotubes from all three groups had insulin-
stimulated glucose and fat oxidation that was 
significantly different from basal.   
• Type 2 diabetics had significantly higher basal 
and insulin-stimulated glucose oxidation than 
leans.   
• Concluded that it was an “extramuscular 
mechanism” not an intrinsic defect.   
Heilbronn et al.  (2007) 
[59] 
Controls 
(3 males, 5 females) 
Family history  
(2 males, 7 females) 
To evaluate if the impaired ability to 
switch between fuel sources is a 
contributing factor to the 
development of insulin resistance 
and T2D or a consequence. 
• After a high CHO meal, serum insulin tended to 
be increased in family history subjects - not 
significantly different from the controls in RQ  
• After a high fat meal, family history subjects had 
diminished capacity to reduce RQ compared to 
controls - suggests an impaired ability to switch 
between fuel sources. 
• Family history subjects had a significantly 
different response of the genes PGC1α and 
FAT/CD36 to a high fat meal. 
Galgani et al. (2008) 
[81] 
N/A – Review article  • Metabolically inflexible subjects have a higher 
fasting RQ and a lower RQ during the clamp. 
• Metabolically inflexible subjects take longer 
(more days) to adjust 24-h RQ to high CHO or 
high fat diet – eventually reach same level as 






Galgani et al. (2008) 
[10] 
59 obese T2D 
(44 C, 12 AA, 3 H) 
42 obese nondiabetic 
(34 C, 8 AA) 
To determine if after controlling for 
glucose disposal rate (GDR), obese 
type 2 diabetics and nondiabetics 
have similar MF to glucose.   
• MF positively correlated with insulin sensitivity 
(GDR). 
• MF negatively correlated to plasma FFA. 
• MF lower in T2D than nondiabetics – significant 
until adjusted for GDR. 
• After the Type 2 diabetic subjects underwent a 
one year lifestyle intervention to lose weight via 
increased physical activity and decreased caloric 
intake, their MF to glucose was significantly 
increased. 
• After controlling for GDF, there was no 
difference in MF to glucose before or after the 
intervention. 
Sparks et al. (2009) 
[51] 
56 young, healthy men To examine the effect of fat cell size 
(FCS) and adipose tissue mass on 
MF. 
• MF was negatively correlated with insulin-
suppressed NEFAs, FCS, percent body fat, and 
adipose tissue inflammation markers. 
• MF was positively correlated with serum 
adiponectin levels. 
Sparks et al. (2009) 
[9] 
78 young, healthy men and 
women 
To determine if sex differences in 
adipose tissue mass and 
characteristics affects MF. 
• MF was higher in women compared to men. 
• MF was negatively correlated to insulin-
suppressed NEFAs and visceral adipose tissue.   
• Women had a significantly higher alternative anti-
inflammatory pathway (M2) marker and higher 
adiponectin levels and expression of lipid 
metabolism genes (PPARγ2, PCK1, SCD1, 
PPARα). 
Meex et al. (2010) 
[7] 
20 healthy males 
18 T2D males 
To evaluate if “exercise training 
could restore mitochondrial function 
and insulin sensitivity in patients 
with type 2 diabetes.” 
• 12-week training program restored MF in obese 
Type 2 diabetic males to the level of the obese 
controls.   
• IS improved significantly in T2D subjects. 
Improved mitochondrial function in both groups, 
with the T2D subjects returning to control levels. 
Stull et al. (2010) 
[11] 
168 men and women of 
various race, age, BMI, and 
diabetes status 
To establish if race and diabetes 
status has an effect on MF. 
• African Americans had a higher MF than 
Caucasians.   
• Non diabetics had a higher MF than diabetics. 
• MF was also found to be inversely correlated to 
age and positively correlated to IS. 




Adamska et al. (2011) 
[52]  
53 men and women with 
normal glucose tolerance 
25 – lean 
12 – overweight 
16 - obese 
To evaluate relationships between 
soluble TNF-α receptor 
concentrations, adiponectin and MF, 
lipid and glucose oxidation, non-
oxidative glucose metabolism, and 
insulin sensitivity in lean and obese 
people. 
• MF positively correlated with adiponectin  
• MF negatively correlated with both sTNFR1 and 
sTNFR2 (soluble TNF-α receptors) 
Færch et al. (2011) 
[57] 
66 men and women 
20 – normal glucose 
tolerance (NGT) 
28 – isolated impaired 
glucose tolerance (i-IGT) 
18 – isolated impaired fasting 
glycemia (i-IFG) 
To examine MF, non-oxidative 
glucose metabolism, glucose and 
lipid oxidation in people with NGT, 
i-IGT, and i-IFG.   
• MF was significantly lower in both the i-IGT and 
the i-IFG groups when comparing them to the 
NGT group. 
• This remained true after adjusting for insulin 
sensitivity and BMI. 
van Herpen et al. (2011) 
[75] 
20 healthy, sedentary 
overweight men 
To evaluate whether high-fat diets 
affect insulin resistance, 
intramyocellular lipid (IMCL), and 
intrahepatic lipid (IHL).   
• When on a high fat diet for 3 weeks, overweight 
men had a decrease in MF and an increase in IHL 
content when compared to their low fat diet 
counterparts. 
• Insulin sensitivity and IMCL were not affected by 
the diet.   
Chomentowski et al.(2011)  
[53] 
40 sedentary men and women 
with various insulin 
sensitivities 
To determine if metabolic 
inflexibility correlated with a 
decrease in mitochondrial content in 
intermyofibrillar or subsarcolemmal 
skeletal muscle. 
• MF was significantly lower in the insulin 
resistant-nondiabetic group and the Type 2 
diabetic group when compared to the insulin 
sensitive-lean control group. 
• MF was positively correlated to intermyofibrillar 
mitochondria content – this was also true when 
evaluated by gender. 
• There was no correlation between MF and 
subsarcolemmal mitochondria content.  
Battaglia et al. (2012) 
[14] 
22 men (18-30 yrs) 
12 – lean 
10 - obese 
To see how exercise training affects 
fatty acid oxidation (metabolic 
flexibility) when consuming a high 
fat diet 
• After 3 days of HFD, lean subjects increased fat 
oxidation but obese subjects did not. 
• Following the exercise training, fat oxidation and 
citrate synthase activity increased for both groups, 





Bergouignan et al. (2013) 
[16] 
44 men and women from 2 
studies 
-Men that detrained for 1 
month (n=9) 
-Sedentary lean (n=10) and 
obese (n=9) men that trained 
for 2 months 
-Active women that 
underwent strict bed rest 
(n=8) or strict bed rest with 
exercise (n=8) 
To evaluate “whether metabolic 
flexibility can be modulated by 
contrasted changes in PAL, 
independent of changes in energy 
balance.” 
• MF measured as the variance of RQ and insulin. 
• Increased PAL results in increased MF 
• Variance in RQ was positively correlated with 
PAL for all groups. 
• Detraining significantly lowered RQ variance and 
increased insulin variance. 
• Training tended to increases RQ variance and 
decrease insulin variance (no statistically 
significant). 
Malin et al. (2013) 
[93] 
12 sedentary, obese men and 
women 
6 – IGT 
6 – IFG + IGT 
To examine “if the presence of 
impaired fasting glucose (IFG) 
affects fuel utilization during 
exercise in adults with IGT.” 
• Metabolic inflexibility defined as using more fat 
and less muscle glycogen during exercise.   
• IFG + IGT group used less muscle glycogen and 
oxidized more fat during exercise than the IGT 
group.   
• IFG + IGT group had significantly higher NEFAs 
and blood glucose. 
Solomon et al. (2013) 
[77] 
20 obese men and women 
(65±1 yr., mean ± SEM) 
“To determine the influence of 
dietary glycemic index on exercise 
training-induced adaptations in 
substrate oxidation in obesity.” 
• MF was improved post-intervention for both diet 
groups. 
• MF was not significantly different between diet 
groups for either pre or post intervention. 
Wijngaarden et al. (2013) 
[83] 
26 men and women 
12 – lean (2 M, 10 F) 
14 – obese (2 M, 12 F) 
“To investigate whether metabolic 
adaptations to prolonged fasting 
differ between lean and obese 
individuals and whether this is 
associated with changes in skeletal 
muscle AMPK signaling pathway. 
• Fasting resulted in an  increase in lipid oxidation 
and a decrease in glucose oxidation from 
baseline; however, the obese subjects had a 
blunted response (significantly lower increase in 
fat oxidation and decrease in glucose oxidation 
than the lean subjects) 
• Reduction in AMPK activity for lean subjects 
only. 
Adamska et al. (2013) 
[58] 
48 sedentary women 
22 – lean 
26 – overweight/obese 
To examine the relationship of 
soluble E-selectin (a marker of 
endothelial dysfunction) with MF 
and insulin sensitivity. 
• Negative correlation between soluble E-selectin 
and metabolic flexibility 
• Metabolic syndrome Z-score positively correlated 
with soluble E-selectin and negatively correlated 




Malin et al. (2013) 
[86] 
24 obese men and women 
(66.7 ± 0.8 yr., mean ± SEM) 
8 – impaired fasting glucose 
(IFG) 
8 – impaired glucose 
tolerance (IGT) 
8 – IFG + IGT 
“To gain mechanistic insight to 
differences in insulin-stimulated 
glucose uptake across the 
prediabetes phenotypes following 
exercise.” 
• MF was significantly increased following the 12 
week exercise intervention in the IFG and IGT 
groups only. 
• The IFG + IGT group had improved MF but was 
not significant. 
Prior et al. (2014) 
[13] 
23 sedentary, 
overweight/obese men and 
women 
To determine if “metabolic 
flexibility during exercise” is lower 
in subjects with impaired glucose 
tolerance (IGT) compared to normal 
glucose tolerance (NGT) 
• During the hyperinsulinemic-euglycemic clamp, 
IGT subjects had a significantly lower MF than 
NGT subjects.  IGT subjects also had a 
significantly lower MF during submaximal 
treadmill exercise (50% and 60% VO2max), the 
IGT subjects also had a significantly lower MF.   
• No correlation between the insulin-stimulated MF 
(clamp) and the exercise MF. 
Kahlhöfer et al. (2014) 
[12] 
32 healthy men (20-37 yrs) To evaluate if “refeeding a low GI, 
moderate-carbohydrate diet 
facilitates weight maintenance.” 
• MF was measured as the ∆NPRQ between the 
end of a refeeding diet period and the end of a 
caloric restriction diet period. 
• ∆NPRQ positively correlated with regain in both 
fat mass and body weight. 
Malin et al. (2014) 
[87] 
20 obese men and women 
(66.3 ± 0.9 yr., mean ± SEM) 
“To examine the effect of exercise 
training on circulating fetuin-A in 
relation to skeletal muscle and/or 
hepatic insulin resistance in obese 
adults.” 
• MF significantly improved following the 12 week 
exercise intervention. 
• MF was negatively correlated with fetuin-A 
(hepatokine that may be linked to development of 
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